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HYDROGEN SULFIDE REGULATION OF KIR CHANNELS 
By Junghoon Ha, M.S. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
Virginia Commonwealth University, 2018. 
 
Major Director: Diomedes E. Logothetis, Former John D. Bower Chair, Department of 
Physiology and Biophysics 
 
 Inwardly rectifying potassium (Kir) channels establish and regulate the resting membrane 
potential of excitable cells in the heart, brain and other peripheral tissues. Phosphatidylinositol-
4,5-bisphosphate (PIP2) is a key direct activator of ion channels, including Kir channels. 
Gasotransmitters, such as carbon monoxide (CO), have been reported to regulate the activity of 
Kir channels by altering channel-PIP2 interactions. We tested, in a model system, the effects and 
mechanism of action of another important gasotransmitter, hydrogen sulfide (H2S) thought to 
play a key role in cellular responses under ischemic conditions. Direct administration of sodium 
hydrogen sulfide (NaHS), as an exogenous H2S source, and expression of cystathionine γ-lyase 
(CSE), a key enzyme that produces endogenous H2S in specific brain tissues, resulted in 
comparable current inhibition of several Kir2 and Kir3 channels. A “tag switch” assay provided 
biochemical evidence for sulfhydration of Kir3.2 channels.  The extent of H2S regulation 
depended on the strength of channel-PIP2 interactions: H2S regulation was attenuated when 
strengthening channel-PIP2 interactions and was increased when channel-PIP2 interactions were 
weakened by depleting PIP2 levels via different manipulations. These H2S effects took place 
		 xiii 
through specific cytoplasmic cysteine residues in Kir3.2 channels, where atomic resolution 
structures with PIP2 gives us insight as to how they may alter channel-PIP2 interactions. 
Mutation of these residues abolished H2S inhibition, and reintroduction of specific cysteine 
residues into the background of the mutant lacking cytoplasmic cysteine residues, rescued H2S 
inhibition. Molecular dynamics simulation experiments provided mechanistic insights as to how 
sulfhydration of specific cysteine residues could lead to changes in channel-PIP2 interactions and 
channel gating.
		 1 
Chapter 1: Background 
1.1 Hydrogen Sulfide, Kir Channels, and Phosphatidylinositol 4,5-Bisphosphate (PIP2)  
The interplay of the biological gas Hydrogen Sulfide (H2S), the inwardly rectifying 
potassium (Kir) channels, and the key signaling phospholipid phosphatidylinositol 4-5-
bisphosphate (PIP2) is the central theme of this thesis and lies at the hub of several independent 
research focuses that delineate their individual contributions in physiological and 
pathophysiological conditions. Our understanding of Kir channels, and their modulation by PIP2, 
elucidates how these players may contribute to altering the excitability of specific cells. H2S has 
more recently been burgeoned as a critical messenger molecule with a broad spectrum of 
significant physiological effects; yet we lack clear understanding about the cellular and 
molecular underpinnings behind its robust effects. The physiological roles of H2S and various 
Kir channels, as well as the eventual convergence of these research tracts, will be described in 
the upcoming background sections. 
1.2 Overview of Hydrogen Sulfide as an Emerging Gasotransmitter  
 Hydrogen sulfide (H2S) is a colorless and flammable gas and has a molecular weight of 
34.08 and vapor density (D) of 1.19, heavier than air (by definition has a D = 1.0) [1]. Having a 
boiling point of -60 °C, H2S remains as a gas in physiological conditions (as well as in laboratory 
freezers in which H2S aliquots are made in aqueous solutions and stored at -20 °C or -80 °C). At 
room temperature (20 °C), 1 gram of H2S will dissolve readily in 242 ml H2O. This gaseous 
molecule provides the bulk of the obnoxious odor one would notice emanating from rotten eggs 
and backed-up sewage well documented for its toxicity to humans in occupational as well as in 
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housing settings [2, 3], and is believed to be a major culprit leading to mass extinctions on earth 
in the end of the Permian period [4]. Given this catastrophic streak on mammalian existence, it is 
not surprising hydrogen sulfide was thought to be solely toxic until relatively recently. The 
production of H2S in mammalian tissues, detected in mammalian tissues from human, rat, and 
cow in the range of 5-160 µM [5, 6], has been known for a long time; however, because of the 
toxicity connotation, it was largely ignored as a metabolic waste. While searching on Pubmed 
database for “Hydrogen sulfide” currently turns up more than 45,000 entries, very few actually 
examine the physiological importance or a beneficial role of H2S to our body.  
  In the past four decades or so, the tides have turned for understanding the physiological 
role of hydrogen sulfide as it has garnered the reputation of a ‘gasotransmitter’ (to be discussed 
later), in the same company as the more traditional and established gaseous molecules like nitric 
oxide (NO) and carbon monoxide (CO) [7]. H2S, like NO and CO, is also highly lipophilic (but 
to a lesser extent) and penetrates the bilayer of cell membranes at ease, having a membrane 
permeability index of 0.97 [1]. H2S is essentially a weak acid in aqueous solution with an acid 
dissociation constant (pKa) of 6.76 at 37 °C and can dissociate into H+ and hydrosulfide anion 
(HS-), which in turn can dissociate into H+ and sulfide anion (S2-) [1].  
 
 
Given that the pKa1 is roughly 7.0 and the pKa2 is 17, there is essentially no S2-  in 
physiological systems (as it will not reach the basic pH of 17), leading to measurements 
of nearly equal amounts of H2S and HS- intracellularly, and approximately a 1:4 H2S/HS- 
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distribution in extracellular fluid and plasma under physiological conditions (pH 7.4 at 
37°C) [1]. The half-life of dissolved H2S in blood indicates it is more stable than NO in protein-
free solutions; however, the physiological half-life may actually be shorter than measured by 
these experiments, as they can be scavenged by methemoglobin to form sulfhemoglobin as well 
as other proteins in plasma [1]. 
1.3  Acid-Labile and Bound-Sulfane Pools of Hydrogen Sulfide 
Intracellular hydrogen sulfide reserves in various tissues are broadly categorized as: 1. Acid-
labile sulfur or 2. Bound-sulfane sulfur [8-10]. Acid-labile sulfur, also known in the field as 
‘brain sulfide,’ is released under acidifying conditions from iron-sulfur complexes of 
mitochondrial enzymes [1]. This pool of sulfur was elucidated through the detection of released 
hydrogen sulfide from rat brain homogenates when subjecting them to acidic solutions [11]. The 
physiological relevance of acid-labile sulfur is being contested as the optimal pH for sulfur 
release from this storage is < 5.4, whereas mitochondrial pH is generally between 7-8 [1].  In 
addition, acid-labile sulfur is difficult to measure directly because iron-sulfur complexes are 
unstable [1]. Bound-sulfane sulfur, characterized by covalent bonds between the sulfur atom with 
its six valence electrons and other sulfur atoms, was detected when additional hydrogen sulfide 
was released when experimenters subjected acid-treated brain homogenates with dithiothreitol 
(DTT), a small-molecule redox agent that would supply a reducing condition to cleave disulfide 
(S-S) covalent bonds [11]. The amount of hydrogen sulfide detected upon additional DTT-
treatment was shown to be about the same as released by the acid, HCl, alone. In addition, 
experimenters showed that exogenous hydrogen sulfide was stored in the pool of bound-sulfane 
and not acid-labile pools of sulfur, as acid treatment did not release additional hydrogen sulfide 
in hydrogen sulfide-pretreated brain homogenates [11]. Sulfane sulfur is quantified by cold 
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cyanolysis and colorimetric measurement of ferric thicyanate [1]. So far, direct measurement of 
hydrogen sulfide levels has been elusive using two technologies: gas chromatography analysis of 
head-space gas or methylene blue spectrometry methods that would not differentiate acid-labile 
sulfur from bound sulfane sulfur [12]. 
The existing forms of bound-sulfane isolated from tissue include persulfides (R-S-SH), 
thiosulfates (S2O3)
 2, thiosulfonate (R-S-SO2-R), polysulfides (RSnR, R is alkyl or aryl), 
polythionates (SnO6
2
), elemental sulfur (S8), and disulfides which have an unsaturated carbon 
adjacent to the C-S bond [7]. The persulfide (R-S-SH) forms of bound-sulfane can occur when 
exposed cysteine residues in a given protein are directly sulfhydrated and thereby, have become 
a candidate focal points for determining how hydrogen sulfide may affect protein activity [7].  
The next section will discuss the enzymes that catalyze the sulfhydration of these cysteine 
residues. 
1.4 Enzymatic Production of Hydrogen Sulfide 
Most of endogenous hydrogen sulfide production occurs enzymatically, whereas only a 
small fraction is generated through the non-enzymatic reduction of elemental sulfur to hydrogen 
sulfide (using reducing equivalents obtained from glucose oxidation) [1]. The major impetus to 
understand the role of H2S in physiology, as opposed to merely its toxicological effects, came 
after several experiments revealed that H2S is ubiquitously generated from L-cysteine by several 
tissue-specific principal enzymes (analogous to the production of NO by nitric oxide synthase): 
cystathionine b-synthase (CBS), cystathionine g-lyase (CSE), and 3-mercaptopyruvate 
sulfurtransferase (3-MST) / cysteine amino transferase (CAT).  H2S thereby signals via 
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sulfhydration, which is a post-translational modification of reactive cysteine residues, analogous 
to N-nitrosylation by nitric oxide [1, 7, 13, 14]. 
1.5. Cystathionine γ-lyase (CSE) and Hydrogen Sulfide in the Cardiovascular System 
Cystathionine γ-lyase (CSE), also known as “cystathionase” or “cysteine lyase,” is 
expressed as two isoforms of CSE in humans (alternatively spliced products that are different by 
132 base pairs) and is a homotetramer consisting of 63 kDa subunits. CSE is expressed 
predominantly in the cardiovascular (CV) system, the respiratory system, liver, kidney, uterus, 
placenta, pancreatic islets, selective areas of the stomach, small intestine, as well as specific 
neuronal tissue in the brain [1, 7, 13, 14]. CSE binds L-cysteine as its substrate and several 
sulfur-containing co-substrates and uses pyridoxal-phosphate PLP, an active form of vitamin B6.  
  The finding that CSE is widely expressed in the cardiovascular system chiefly motivated 
several researchers to focus on the role of H2S in the cardiovascular system, leading to the design 
of in-vivo and in-vitro experiments that interfered with endogenous production of H2S and/or 
added exogenous H2S to cardiovascular tissue/cells, using H2S donors like L-cysteine or H2S 
salts like sodium hydrogen sulfide (NaHS) and sodium sulfide (Na2S) [7, 14]. These studies have 
led to the striking discovery that H2S confers protection to the heart through diverse processes: 
combating cellular necrosis, apoptosis, oxidative stress, inflammation, as well as through the 
promotion of angiogenesis and regulation of mitochondrial respiration [13]. 
To better understand the broad role of CSE in mammals, two research teams from 
Canada and the United States spent 5 years to develop CSE-KO mice and test their phenotype 
[15]. This seminal work concluded in 2008 presents several major advancements in H2S 
research. These experiments first showed that most, if not all, the hydrogen sulfide production in 
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the CV system is mediated by CSE. The most noticeable phenotype in CSE-KO mice was that 
they developed hypertension with an onset of 8 weeks. Lack of endogenous H2S production is 
most likely the major reason since injection of exogenous H2S into these mice rescued them from 
hypertension [15]. They also showed that the hypertension was due to severely damaged 
endothelium-dependent relaxation of small resistance arteries (in contrast to relaxation of larger 
arteries by carbon monoxide and nitric oxide gases) [15]. The authors’ explanation for how 
hydrogen sulfide stimulated vasodilation is as follows: vascular endothelium generates H2S via 
CSE action, and the newly produced hydrogen sulfide then produces additional H2S in a 
positive-feedback mechanism involving the activation of muscarinic receptors and calmodulin 
stimulation. The H2S, generated in this loop, then diffuses over to both endothelial and vascular 
SMCs to induce vasorelaxation. This described mechanism is very distinct from that of another 
EDRF, NO, and will be more thoroughly described in the background section that focuses on 
hydrogen sulfide effects on Kir channels [7, 14].  
Interestingly, overexpressing CSE, or otherwise increasing the production of hydrogen 
sulfide, has a direct cardioprotective effect when the myocardium is deprived of oxygen and 
undergoing ischemic insults. More specifically, overexpressing CSE in the myocardium has also 
been shown to limit mouse cardiac ischemia-reperfusion damage (reduced myocardial infarct 
size) due to increased endogenous hydrogen sulfide levels [16]. Other effects from altered CSE 
expression and changed H2S levels have been demonstrated in inflammation, atherosclerosis, 
diabetes, asthma as well as in erectile dysfunction (ED) [17-22].  
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1.6. Cystathionine b-synthase and Hydrogen Sulfide in the Nervous System 
Cystathionine b-synthase (CBS) was first isolated by Braunstein et al. in 1969 as a serine 
sulfhydrase [23]. Like CSE, the N-terminal domain of CBS contains binding sites for both PLP 
and heme (protoporphyrin IX) [24]. The heme domain in CBS coordinates to both histidine and 
cysteine amino acids as axial ligands, in humans and rodents, and has been suggested as the 
enzyme’s redox sensor, because deletion of the domain renders CBS insensitive to oxidative 
stress [25]. The carboxy-terminus of CBS contains an autoinhibitory domain of 140 residues, and 
binding to S-adenosyl methionine (SAM), the common co-substrate involved in methyl transfers, 
transmethylation, transsulfuration, and aminopropylation pathways, removes the autoinhibition 
[26]. Just as with CSE, CBS catalyzes the production of H2S using L-cysteine (as well as 
homocysteine). The best characterized reaction catalyzed by CBS is the condensation of 
homocysteine and serine: L-serine + L-homocysteine to form cystathionine and water, which can 
also feed into the biosynthetic production of hydrogen sulfide [1, 7, 14]. 	
CBS expression is significant in the brain as the primary physiological source of H2S in 
the central nervous system [1, 7, 13, 14]. Unlike CSE, CBS expression is rare or absent in the 
cardiovascular and respiratory systems, testes, adrenal, and spleen in rats, mice, or humans.  
Initial studies showed that CBS was found to be highly expressed throughout the brain, 
especially in the hippocampus and cerebellum, when compared with the cerebral cortex and 
brain stem. In contrast, Enokido et al argued that CBS is preferentially expressed in astrocytes 
rather than neurons, which is verified by more thorough combined biochemical and histological 
examination, as well as more sensitive in situ hybridization techniques [1, 7, 14]. Recent findings 
suggest that CBS mainly localizes to astrocytes (and very specific hippocampal and striatal 
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neurons) [7]. Additionally, one study showed the basal hydrogen sulfide level in unstimulated 
human astrocytes is 3.0 µmol/g protein, 7.9-fold higher than in cultured microglia [27]. 
Analogous to the H2S experiments that revealed the role of the gas in cardiovascular 
vasodilation, breakthrough findings linking the H2S levels and functional changes in the brain, 
occurred when Abe and Kimura reported that H2S donor, NaHS, facilitated the induction of 
hippocampal long-term potentiation (LTP) at micromolar concentrations [28]. This effect 
revealed the physiological role of  hydrogen sulfide in the brain contrary to the toxic connotation 
it generally holds. The expression of CBS mRNA in the hippocampus using Northern blots [28] 
was further confirmed. Pharmacological manipulation of CBS activity altered H2S production 
correspondingly [28]. Although it was not known up to that time whether altering endogenous 
H2S level affects the long-term potentiation (LTP) process, a “neuromodulatory” role of 
exogenous H2S in the brain was then first described.  
Unfortunately, generating homozygous knock-outs (KOs) of CBS proved to be fatal to 
the mouse, yielding very little information compared to the CSE knockout mice, except that it is 
vital to the development of the mouse’s brain as their life span was about 4 weeks [29].  
Generation of heterozygous (HT) mice presented with the hyperhomocysteinemia phenotype, 
twice the normal homocysteine level, one of the substrates of CBS [29]. However, it was 
difficult to probe for the role of CBS and the hydrogen sulfide it produces, given that 
endogenous hydrogen sulfide production was still significant in the heterozygous mice  in these 
experiments [29]. There is evidence that altered expression of CBS (and endogenous hydrogen 
sulfide) in vivo leads to various neurodegenerative diseases while replenishment with exogenous 
H2S reversed the pathology [1].  
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1.7 3-Mercaptopyruvate sulfurtransferase (MST) and Cysteine amino transferase (CAT) 
Mercaptopyruvate sulfurtransferase (MST) and cysteine amino transferase (CAT) also 
enzymatically produces hydrogen sulfide, but defects in MST do not lead to life-threatening 
phenotypes in mammals as altered CBS or CSE activity [1]. In the brain, MST was shown to be 
localized to the hippocampal pyramidal neurons, cerebellar purkinje cells, and mitral cells of the 
olfactory bulb. Also, MST was shown to be predominantly localized in proximal tubular 
epithelium of kidney as well as pericentral hepatocytes in the liver [30]. Like CBS and CSE, 
MST and CAT utilizes PLP as a cofactor, but MST uniquely relies on zinc as a cofactor.  In 
cells, MST and CAT have been localized in cytosol and mitochondria [31].  Cooperatively, CAT 
converts L-cysteine to 3-MP, and MST transfers sulfur from 3-MP to a bound sulfide or other 
sulfur acceptors to form elemental sulfur [32].  The direct outcome of the pathway is the 
production of sulfane sulfur (or bound sufur). H2S will be formed through reduction of atomic 
sulfur or releases from this bound sulfur, either in the thiosulfate or persulfide form.  Although it 
is clear in in-vitro experiments that CAT/MST generates hydrogen sulfide, the physiological role 
of CAT/MST still remains unclear as experiments on CBS or CSE knockout mice, in which 
exposing rat liver and kidney cells to exogenous L-cysteine in CSE K/O mice failed to produce 
meaningful hydrogen sulfide in experiments [33]. In addition, the measurement of 3-MP, the 
only known sulfur donor for MST is elusive and has not been detected in-vivo, given its 
instability [1].  
1.8. Biology of Protein S-Sulfhydration (Persulfidation)  
Recently, hydrogen sulfide has been shown to signal through the covalent modification of 
cysteine residues through S-sulfhydration (or persulfidation) or the conversion of cysteine –SH 
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groups to hydropersulfide (-SSH groups) [7, 14].  S-sulfhydration (also referred to as “short-term 
as sulfhydration”) is analogous to S-nitrosylation which occurs between NO molecules and 
cysteine residues of targeted proteins [7, 14]. Although there are remarkable similarities between 
S-sulfhydration and S-nitrosylation, there are several key differences: about 10-25% of 
endogenous glyceraldehyde 3-phosphate dehydrogenase (GAPDH), beta-tubulin, and actin are S-
sulfhydrated in vivo whereas only about 1-2% of coverage may be applicable to NO [7, 14].  The 
functional outcome of S-sulfhydration and or S-nitrosylation may be distinct. For example, in the 
case for GAPDH activity, S-sulfhydration has been attributed to increases in functional activity 
whereas N-nitrosylation appears to decrease protein activity [34]. The GAPDH protein, for 
example, has sixteen cysteine residues that may be subjected to post-translational modification. 
GADPH activity has been shown to increase either through overexpression of CSE or direct 
application of hydrogen sulfide [34]. On the contrary, incubating purified GAPDH with NO 
modified its four cysteine residues per molecule, leading to the abolishment of its activity [35]. 
Studies have also shown that S-sulfhydration is more stable relative to S-nitrosylation, which 
makes it easier to detect via mass-spectrometry [1].  Also, S-sulfhydration occurs under resting 
conditions without the requirement of additional physiological stimulation, evidenced by the 
reduction of GADPH sulfhydration in CSE-KO mice and endogenous hydrogen sulfide 
production in CSE-KO mice, despite the fact that GADPH was unchanged [34]. In contrast, 
basal S-nitrosylation remained unchanged when all NOS enzymes, neuronal NOS (nNOS), 
eNOS and iNOS were knocked out in mice [35]. 
 A requirement for S-sulfhydration is the availability of free thiol (–SH) groups. If 
oxidizing conditions cannot be met and the existence of disulfide bonds blocks the access of 
hydrogen sulfide to sulfhydryl groups, a two-step process could be involved [7].  Hydrogen 
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sulfide could disrupt disulfide bonds within proteins by acting as a reducing agent, which would 
expose free SH groups [7]. Then, another hydrogen sulfide molecule could bind exposed SH 
group and lead to S-sulfhydration. The prospect of competition occurring between H2S and NO 
on the same exposed cysteine residue and thereby differentially altering protein function is an 
intriguing topic not properly addressed experimentally.  Also, no endogenous desulfhydration 
molecule has been discovered for S-sulfhydration analogous to how S-nitrosylation can be 
reversed by denitrosylation with thioredoxins [36].  H2S itself may also function as a 
desulfhydration molecule due to its reducing property the same way it has been shown to reduce 
disulfide bonds under specific circumstances. Or this desulfhydration role may also be performed 
by other capable endogenous reducing molecules like glutathione [1]. 
1.9 Methods to Detect Protein S-Sulfhydration 
 So far, the most improved technique employed to detect S-sulfhydration is the TAG-
Switch Assay. This assay uses methylsulfonylbenzothiazole (MSBT) to block all thiol groups, 
after which a reagent compromising a nucleophile and a biotin moiety is reacted with the protein 
solution. The nucleophile only recognizes the MSBT-bound persulfide groups and not the free 
thiol group, so that only sulfhydrated proteins are then enriched using streptavidin conjugates 
and then analyzed by western blotting. The MSBT can further be tethered to fluorophores or 
other reporter molecules instead of biotin for added sensitivity.   
The TAG-switch Assay is the derivative of another technique, the Biotin Switch Assay, 
which was used to identify the bulk of S-sulfhydration experiments and therefore worth 
mentioning despite agreement in the field that it is not as reliable [37]. In this modified biotin 
switch assay, a variant of the assay developed to detect S-nitrosylation of proteins, the 
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sulfhydrated protein is treated with methyl methanethiosulfonate (MMTS) to block specifically 
unmodified cysteine residues. In this technique, a control reaction is treated with dithiothreitol 
(DTT) to reduce persulfide groups, and then blocked with MMTS. After removal of excess 
MMTS, the samples are labeled with biotin, which interacts with the thiol group. The 
biotinylated proteins are enriched by affinity capture using streptavidin conjugates, which 
specifically bind to biotinylated proteins, and then analyzed by western blotting [7]. The control 
samples treated with DTT, where the persulfide group is reduced back to the corresponding thiol, 
will not yield a signal on western blots. The major issue with this technique has been the findings 
that in the hands of many investigators MMTS would also label the free thiol-groups, which 
produced a great deal of false positive results and therefore is no longer the standard technique 
for measuring S-sulfhydration [37]. Therefore, in a gamut of these studies, the positive results 
were corroborated by mass spectrometry to detect specific modification of cysteine residues [7].  
1.10 Methods to Detect Free Hydrogen Sulfide 
The physiological range of H2S in the circulation has been estimated at 10 –100 µM in 
healthy animals and humans [38-41]. Interestingly, this circulating H2S amounts seem unaffected 
by aging. A study revealed no change in serum H2S concentration among three age groups of 
humans spanning 50-80 years of age (34 –36 µM)  [42]. In rat, mouse, and rabbit blood plasma, 
H2S was detected at micromolar ranges as well has been reported in many other vertebrates [1]. 
Endogenous levels of H2S in rat brain homogenates are 50–160 µM [1] . Similar H2S levels were 
reported in the liver, kidney, and pancreas [1] . H2S production was clearly measured in the 
cardiovascular system [41, 43].  
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Measurement of hydrogen sulfide in animal serum is and remains a complicated technical 
matter. Whereas there is agreement to the hydrogen sulfide ranges detected in most studies in-
vivo, efforts to detect hydrogen sulfide levels in-vitro on specific tissue cell lines have revealed 
significantly lower ranges or sometimes even concluded that hydrogen sulfide cannot be 
detected. One explanation for these low values of H2S in vitro is the rapid decay within 30 
minutes of H2S concentrations, from micromolar to undetectable levels [44]. Another related 
concern is the reliability of equipment used to measure the hydrogen sulfide themselves. The 
real-time polarographic sensor was initially developed by Doeller et al. in 2005 [45]. Using the 
same kind of house-made sensor, Benavides et al. [43] demonstrated that red blood cells 
produced H2S. In two other studies using polarographic sensors, free H2S concentrations in 
whole rat blood have been detected at 5 µM [45]. These experiments could have been helped by 
simultaneous employment of the polarographic sensor and other detection methods for H2S 
detection validating the detection of H2S in the serum. In contrast to the sulfur ion-selective 
electrode which detects total sulfur in the blood including its acid labile, bound, or free H2S 
forms (discussed in the bound or unbound hydrogen sulfide section), the polarographic sensor is 
sensitive only to freely dissolved H2S gas. It is possible that the readings are simply accurate and 
reflect the possible reality that significant amount of H2S in circulation may not be in a free form 
as dissolved gas [1] .   
Focusing on tissue-specific hydrogen sulfide production (rather than in serum), the gas 
chromatography technique also produced similar variances in hydrogen sulfide detection. Furne 
et al. [46] reported very low tissue production of H2S in homogenized mouse brain and liver in 
the nanomolar range of concentrations. An interesting comparison for this observation is that 
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Hyspler et al. [39] also used gas chromatography-mass spectrometry (GC-MS) analysis and 
detected human whole blood H2S levels at 35– 80 µM. Even using a polarographic sensor, others 
have detected significant tissue production of H2S from the brain and liver [45].   
Many of the current H2S measurement techniques, such as spectrophotometry, 
chromatography, and ion-selective electrodes, were originally developed to meet the industrial 
demand for monitoring H2S pollution in the environment. [1] These techniques are usually 
invasive and require a bulky quantity of samples, and they also do not take account for the 
conditions of biological studies, such as the existence of H2S scavenging molecules, interference 
of hemoglobin or other pigment compounds, redox balance, pH changes, etc.  
1.11. L-Cysteine Biosynthesis via Reverse Transsulfuration 
Reverse transsulfuration describes the metabolic pathway in which methionine, an 
essential amino acid, is converted to cysteine in vertebrate and fungal species [47]. Whereas, 
transsulfuration is a term which describes the opposite interconversion process: the conversion of 
methionine from cysteine, catalyzed by cystathionine lyase (CBL) and cystathionine synthase 
(CGS) in plant and bacterial species  [47]. Reverse transsulfuration contributes significantly to 
the intracellular pool of cysteine in mammals as they possess several flux-controlling enzymes to 
shift the equilibrium in favor of cysteine. This biosynthetic pathway serves as a catabolic 
machinery for the breakdown of methionine and its toxic intermediates including homocysteine, 
a major clinical marker for several human physiological disorders [48]. At elevated levels, 
homocysteine is an independent risk factor for cardiovascular diseases and other complex 
physiological disorders [48].   
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  In addition to being the key product of reverse transsulfuration, cysteine is also used for 
biosynthesis of glutathione and is the primary substrate for hydrogen sulfide biosynthesis 
regulated by CBS and CSE, enzymes described earlier. CBS can also catalyze the condensation 
of homocysteine and serine to form cystathionine in an irreversible reaction favoring its 
hydrolysis by CSE to produce cysteine, alpha-ketobutyrate, and ammonia [48]. Thus, reverse 
transsulfuration describes the transfer of methionine sulfur to serine to synthesize cysteine. 
Tissues unable to conduct sufficient reverse transsulfuration, lacking the biosynthetic machinery, 
require exogenous source of cysteine and must be able to export homocysteine for further 
metabolism by other tissues [48]. There are severe physiological consequences due to buildup of 
metabolic intermediates, homocysteine as well as interrupted cysteine production. 
1.12.  Cysteine Drives Endogenous Hydrogen Sulfide Production 
L-Cysteine is derived from the dietary amino acid methionine via reverse transsulfuration 
[1]. Although L-cysteine is classified as a non-essential amino acid, which means that mammals 
can biosynthesize L-cysteine under normal physiological conditions, major deficiencies in the 
biochemical (reverse transsulfuration) pathway, which converts methionine to cysteine, or lack 
of dietary methionine, an essential amino acid, will basically confer L-cysteine with the status of 
an essential amino acid [1]. In such circumstances, the burden of cysteine production will rely 
solely on the enzymes that sulfurylate O-acetylhomoserine to give homocysteine, which then 
joins the reverse transsulfuration pathway to be converted to cysteine [49].  Thereby, 
experimenters could lower L-cysteine levels, and thereby reduce endogenous hydrogen sulfide 
levels by depriving animals of methionine- or cysteine- containing diets. Several studies 
demonstrated that exogenous L-cysteine application limited the infarct size in ischemic heart, in 
		 16 
which the protective effect of L-cysteine was believed to be due to the enhanced endogenous 
production of hydrogen sulfide via CSE action [50]. Inhibition of CSE activity with DL-
propagylglucine (PPG), an antibiotic produced by Streptomyces, applied simultaneously with 
PPG abolished the effect of L-cysteine [50].  
However, not all biological effects of cysteine can easily be explained by production of 
hydrogen sulfide. The side chains of cysteine composed of non-polar thiol confers overall 
hydrophobicity to the amino acid. Used as a nucleophile, this thiol side chain has been shown to 
participate in various enzymatic reactions [1]. In addition, thiol-side groups when oxidized can 
form the derivative cystine, which plays a critical structural (and thereby functional) role in 
many proteins [1]. Addition of L-cysteine can increase the physiological pool of other sulfur-
containing amino acids, especially cysteine, methionine, and S-adenosylmethionine, are of which 
are essential for the growth and activities of all cells [1]. For example, when CSE-KO mice were 
fed with cysteine-limited diets, they exhibited decreased levels of cysteine, glutathione, and 
hydrogen sulfide and most notably increased plasma homocysteine levels [51]. Animals 
presented with growth retardation and shortened life span with their cause of death being tied to 
paralysis of upper extremities and skeletal muscle atrophy [52]. Injecting CSE-KO animals with 
NaHS daily did not reverse or stop the cysteine-limiting diet induced decrease growth retardation 
of CSE-KO mice [52]. Only reintroducing cysteine to their diets allowed the animal to recover 
from these developmental events[52]. Experimenters thus concluded that CSE is required for 
cysteine biosynthesis and that sufficient cysteine supply is a prerequisite ensuring normal growth 
development of mice in the absence of the CSE enzyme in these animals. 
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1.13. PIP2 Activation of Kir Channels  
Inwardly rectifying potassium channels (Fig. 1) establish and regulate the resting 
membrane potential of excitable cells in tissues such as brain and heart. A wealth of 
electrophysiological, structural, and biochemical studies has revealed that a biological 
phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), is a key direct activator of Kir 
(inwardly-rectifying K+) channels. Direct phosphoinositide control of the activity of ion channels 
has emerged as a critical molecular theme concerning the activation of Kir (inwardly rectifying 
K+) channels. Various experiments on Kir channels have revealed the critical role of a specific 
phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PIP2) in their gating. Several post-
translational modifications, such as phosphorylation of specific residues, have been shown to 
directly or allosterically alter K+ channel interaction with PIP2 [53, 54]. 
PIP2 is a signaling phospholipid (Fig. 2) and has been increasingly appreciated in the past years: 
first as the precursor of ubiquitous downstream signals (inositol-trisphosphate IP3, diacylglycerol 
DAG, and PIP3), later serving a role in membrane localization of proteins in different 
membranous compartments, and more recently as a direct modulator of the activity of 
transmembrane proteins, such as ion channels and transporters [55-57].  In the intervening years, 
researchers showed that most ion channels tested to date depend on adequate PIP2 levels to 
maintain their activity, suggesting a conserved mechanism by which ion channel function is 
regulated by PIP2. Co-crystal structures of inwardly rectifying K+ (Kir) channels with PIP2 have 
highlighted the nature of the direct interactions of PI(4,5)P2 at a key position capable of 
modulating two of the channel gates, the helix bundle crossing (HBC) and the cytosolic  
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Figure 1.  Dendrogram of the Kir family. The Kir superfamily contains at least 15 members in 
six distinct subfamilies (Kir1, Kir2, Kir3, Kir5, Kir6, Kir7) that respond to various cytoplasmic 
and extracellular modulators; channels are two-membrane spanning (2TM) and share about 30-
40% homology among the Kir subfamilies and >60% within the subfamilies. Kir channels were 
characterized strictly by their electrophysiological behavior as they allow more conduction in the 
inward than in the outward direction due to reduced open probability in depolarizing conditions 
across the membrane.  However, in physiological conditions, Kir channels have a key role in 
stabilizing the membrane potential.  In addition, regulation of these channels can alter the 
membrane potential and cellular excitability. 	
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Figure 2. Phosphatidylinositol (4,5)-bisphosphate and dioctanoyl PI(4,5)-bisphosphate 
(diC8). PtdIns(4,5)P2 is a minor phospholipid component of the cytoplasmic leaflet in plasma 
membranes, where it is a significant substrate for a number of membrane-localized signaling 
proteins. PtdIns(4,5)P2 is primarily made by the type I phosphatidylinositol 4 phosphate 5 
kinases from PI(4)P. A. Long-chain aa-st PI(4,5)P2. Schematic of endogenously produced 
PI(4,5)P2.  B. Soluble dioctanoyl PI(4,5)P2  (diC8).  Schematic of chemically modified 
PI(4,5)P2. The palmatoyl group and 19-carbon long chain of aa-st PI(4,5)P2 have been replaced 
by shorter, more soluble singly-bonded 8-carbon long fatty acid chains. 
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Figure 3.  PIP2 signaling pathway indirectly modulates ion channels through the activation 
of protein kinase C (PKC) and Ca2+-dependent enzymes using secondary messengers. 
Activation of phospholipase C (PLC) results in the hydrolysis of phosphatidylinositol (PIP2) to 
produce inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 activates Ca2+ channels 
in the endoplasmic reticulum (ER) triggering the release of Ca2+ from intracellular stores. The 
cytoplasmic rise in Ca2+ level and DAG then activate protein kinase C (PKC), which in turn 
phosphorylates K+ channels, thereby modulating current across the membrane. 	
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or G-loop gates. Ever since, direct phosphoinositide control of the activity of ion channels has 
emerged as a critical molecular theme concerning the activation of Kir (inwardly rectifying K+) 
channels.  
Prior to the crystal structures, a flurry of electrophysiological experiments on Kir 
channels had corroborated the critical role of a specific P(4,5)P2 in their gating. Hilgemann and 
colleagues demonstrated that phosphoinositides, highly negative-charged anionic lipids with 
myo-inositol in the head group can also directly modulate channel activity [56]. Their 
experiments revealed that phosphoinositides such as phosphatidylinositol-4,5-bisphosphate 
(PIP2) can activate native cardiac KATP channels. Ensuing studies by Fan and Makielski [55] 
uncovered that PIP2 modulation of ion channels was not only limited to KATP channels, but also 
applied to other inwardly rectifying potassium (Kir) channels such as Kir1.1 and Kir2.1, and 
these findings were eventually extended to all other members of the Kir family of channels. In 
the background of channel- PIP2 interactions, several post-translational modifications on the Kir 
channels, such as phosphorylation of specific channel residues, have been shown to directly or 
allosterically alter Kir channel interaction with PIP2 [53].  
In general, phosphatidylinositol-4,5-bisphosphate, PI(4,5)P2, was shown to be the most 
abundant and reliable of the phosphoinositides in activating Kir channels (albeit differentially) 
compared to other naturally occurring phosphoinositides: PI, PI(4)P, PI(3,4)P2, PI(3,5)P2 and 
PI(3,4,5)P3 [58-61]. Although, the parent compound phosphatidylinositol (PI) can become 
phosphorylated at the 3, 4, and 5 positions of the inositol ring in every combination, PI(4,5)P2 
(Fig. 2) is the most abundant poly-phosphoinositol making up 1% of the total phospholipids of 
the plasma membrane [62]. PIP2 has three phosphate groups, one of which is in a phosphodiester 
bond, and a net charge near -5 at neutral pH [63]. In the late 1970s, PIP2 was shown to be the 
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substrate of plasma membrane-delimited enzyme phospholipase C (PLC), which hydrolyzes PIP2 
into two secondary messengers (Fig. 3), soluble inositol 1,4,5-trisphosphate (IP3) and membrane-
anchored diacylglycerol (DAG) [64]. IP3 and DAG were subsequently shown to release Ca2+ 
from intracellular stores within the cell and to recruit and activate protein kinase C (PKC), 
respectively [63]. Moreover, PIP2 was shown to serve as a targeting anchor for proteins that 
catalyze endocytosis and exocytosis such as GTPases, PKC, and other components of the actin 
cytoskeleton [64]. Since PIP2 served as an epicenter for these two signaling pathways that affect 
ion channel function indirectly through secondary messengers, it became critical to perform the 
necessary control experiments to ensure that electrical phenotype was a result of direct PIP2-
channel interactions. 
As PIP2 direct activation of Kir channels became evident, researchers began focusing on 
where and how PIP2 interacts with Kir channels. First attempts examined the effects of naturally 
occurring phosphoinositol lipids on cloned Kir6.2/SUR1, through their direct application to the 
cytoplasmic membrane side of excised patches [58]. Channel activity in these experiments was 
allowed to rundown, a process which typically occurs in excised patches due to hydrolysis and/or 
dephosphorylation of the endogenous phosphoinositide PIP2. Several phosphoinositides were 
tested to see whether they could restore channel function. As PI(4,5)P2 emerged as the most 
effective of the phosphoinositides in recovering (activating) channel activity, it became clear that 
Kir channels exhibited distinct affinities (as well as stereospecific requirements) with the 
phosphate groups on inositol carbon positions 4 and 5 [65]. Hypothesizing that the acidic 
negatively charged phosphates of PIP2 (at neutral pH) interact electrostatically with basic 
positively charged residues on ion channels (Fig. 4), laboratories focused on identifying channel 
regions that are vital for ion-channel modulation by PIP2.  
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Figure 4. Stimulatory effect of PIP2 on Kir channels via direct regiospecific-electrostatic 
interactions.  Two highly negative-charged phosphate groups (depicted here by red circles) 
attached to the 4 and 5 carbons of inositol (represented by hexagonal inositol ring) in the inner 
leaflet of the plasma membrane interact with candidate positively charged residues that are 
highly conserved in the Kir superfamily. Net inward movement of potassium ions depicted by 
the blue arrow is indicative of hyperpolarizing conditions typically applied to membranes 
expressing Kir channels. A. Schematic of a Kir channel in the inactivated closed state. When the 
level of PIP2 is low (often depleted through PIP2 dephosphorylation, hydrolysis, or run down in 
excised patch experiments), Kir channel remains in the closed state. B. Schematic of a Kir 
channel in the activated open state via the binding of PIP2 to the channel: relies both on the 
spatial distribution of phosphate groups on the inositol ring as well as electrostatic interactions.		
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Figure 5.  A Published Crystal Structure of Kir3.2 (GIRK2) Channel reveals direct 
Channel-PIP2 Interactions. (Whorton et. al. Cell 2011). Side view of GIRK2 crystal 
structure(PDB code 3SYA). Labelled: M1 and M2 transmembrane helices, a selectivity filter, 
two gates: Inner-helix gate and G-loop gate, and turret, known region to bind toxins. B. Key 
Positively-charged residues of GIRK2 channel involved in PIP2 binding (shown in space-
filing). PIP2 is represented as in stick molecule conformation (green arachidonyl and stearyl fatty 
acid chains).  	
	
	
 
 
 
Figure adapted from Whorton et. al. Cell 2011 and generated by Dr. Yu Xu. 
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These electrophysiological patch experiments required the use of modified shorter PIP2 analogs 
such as dioctanoyl PIP2 (diC8) (Fig. 2), which due to their water solubility were much easier to 
wash out of membranes [65]. Logothetis and coworkers utilized diC8 to determine the apparent 
affinity of PIP2 for a particular Kir channel and compare it to other channels [66, 67].  
The conserved basic sites that bind PIP2 were unveiled through systematic mutagenesis of 
highly conserved basic residues in the cytoplasmic domains of Kir channels [65]. Mutant 
channels, whose basic residues were replaced with neutral residues, exhibited decreased recovery 
of ion channel activity upon addition of exogenous PIP2 to the cytoplasmic side. Furthermore, 
mutant channels showed increased sensitivity to inhibition by poly-L-lysine (a PIP2 scavenger) 
as well as PIP2 specific antibodies suggesting that the mutations reduced apparent PIP2 affinity 
[68]. Subsequent experiments also showed that one could swap a mere residue in Kir2.3 with a 
corresponding residue in a related Kir channel (Kir2.1) (Fig. 1) that is more sensitive to PIP2, to 
increase its apparent affinity to PIP2 and vice-versa [69].  Interestingly, single point mutations in 
the pore helix of Kir3.x channels that exist physiologically as heterotetramers enhanced the 
activity and channel-PIP2 affinity of various tissue specific homomeric Kir3.x channels when 
they are expressed heterologously (referred to as Kir*; where Kir3.1* has the F137S mutation, 
Kir3.4* or G4* has the S143T mutation or where Kir3.2* has the E152D mutation).  
Methods were devised to alter cellular pools of PIP2 such as the use of Wortmannin, a 
specific phosphatidyl-inositol 3-kinase (PI3K) inhibitor at nanomolar concentrations, when used 
at high micromolar concentrations can inhibit phosphatidyl-inositol 4- kinase (PI4K), reducing 
the available pool of PI4P (phosphatidyl-inositol 4-phosphate) for conversion into PIP2 by PIP5K 
(phosphatidyl-inositol phosphate 5-kinase). The co-expression of PIP5K would on the other hand 
		 26 
increase the level of cellular PIP2 in the cell. The co-expression of Ci-VSP, a voltage-activated 
PIP2 5-phosphatase, allowed researchers to dynamically deplete PIP2 levels at the membrane and 
concurrently assay the relative strength of channel-PIP2 interactions by examining the kinetics 
and recovery of Kir channels (i.e. observe what happens to current as PIP2 pools are reduced 
simultaneously [54, 70, 71].  Thus, our understanding of Kir channel modulation by PIP2 has 
offered great insights into mechanisms underlying the gating of ion channels.  
1.14. Role of Hydrogen Sulfide on Kir Channels  
One of the major breakthrough experiments revealing a clear physiological role for 
hydrogen sulfide came in 2001 when Zhao et al. for the first time cloned the CSE gene from rat 
vascular tissues and demonstrated that both the expression and activity of CSE can be 
upregulated by NO, leading to increased production of H2S from vascular smooth muscle cells 
(SMCs) [41]. The team also showed that, unlike NO that relaxes blood vessel walls by activating 
guanylyl cyclase to synthesize cGMP, the specific molecular targets of H2S in vascular SMCs 
are KATP channels [41]. This is the first molecule target of H2S identified in the cardiovascular 
system. By stimulating KATP channels, H2S causes vasorelaxation within a physiologically-
relevant concentration range [41].  
In the many clinical research endeavors that sought to identify the role of hydrogen 
sulfide in cardiovascular diseases, hydrogen sulfide emerged as a therapeutic agent for ischemic 
heart disease, the pathophysiological state characterized by reduced blood supply to the heart and 
the most common cause of death in most western countries [72].  Thereby, navigating through 
the complex pathophysiology and exploring therapeutic measures pertinent to novel players like 
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H2S became paramount to our efforts to better combat the disease. While, some of these diverse 
effects were simply attributed to H2S altering the redox state of cellular environments [73], other 
profound effects are thought to take place via persulfidation of proteins (addition of persulfide -
SSH moieties also described as S-sulfhydration), the post-translational modification of 
regulatory cysteine (Cys) residues (analogous to N-nitrosylation of proteins at Cys residues by 
the gas nitric oxide, NO) [1, 7, 14]. In these studies, the extent of protein persulfidation was 
detected previously by biochemical techniques, such as the Biotin Switch Assay [34], and the 
more recently accepted gold standard, the Tag Switch Assay (TAG) [37], as well as by mass 
spectrometry [74].  
One seminal work actually bridged a specific persulfidation of a regulatory cysteine 
residue in an ion channel, KATP channel (Kir6.2 channel) to the enlargement (vasodilation) of 
blood vessels, demonstrating the striking influence of H2S on an ion channel expressed in the 
cardiovascular system [75]. While lacking the same degree of clarity as to providing a 
mechanistic role for H2S in vasodilation, experiments on rat myocardium in-vivo, showed that 
exogenous H2S is able to confer cardioprotection and diminish the myocardial infarct size 
following ischemia and reperfusion (I/R) injury, either through pre-I/R [16, 76, 77] or post-I/R 
[78] treatment with exogenous H2S. In agreement, endogenously induced H2S, through the 
overexpression of protein kinase G (PKG-Ia), which increases CSE expression in the 
myocardium, also lead to cardioprotective effects following I/R injury [79]. Stunningly, the 
addition of a KATP channel blocker, glibenclamide, abrogated the beneficial effects of H2S in 
both scenarios [77, 78]. It is unclear whether KATP currents, by hyperpolarizing myocardium 
affected by ischemia, permit the beneficial effects of H2S, or whether the role of H2S is to 
directly activate KATP and through this mechanism (mainly) reduce the extent of damage by I/R 
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injury. Such findings strongly make the case for understanding how alterations in cell excitability 
by H2S may contribute to physiological effects that are beneficial (or harmful) to the cardiac 
tissue (atria and ventricles). 
It is also well established that the activation of KATP channels (Kir6.2 channels) in the 
myocardium has been shown to play a pivotal role in cardioprotection during I/R injury 
(independent of exogenous H2S treatment) and is a crucial component of the phenomenon 
termed cardiac ischemic pre- conditioning [80]. Overall, these results describe the clinical 
beneficial effect of H2S when Kir6.2 channels are active, setting the stage for us to understand 
the mechanistic details of how H2S persulfidation activates Kir6.2 channels in the heart as well 
as to explore whether it targets other ion channels, especially other closely related members of 
Kir (inwardly rectifying K+) channels that are widely distributed in the myocardium (i.e. Kir 2.x, 
and Kir3.x channels) [81]. If H2S does affect Kir channels at large, the gaseous molecule would 
further orchestrate the passive and active electrical properties of the heart drawing attention to 
differential expression of such target ion channels in the myocardium (in atrial or ventricular 
tissue) as well as the potential pharmacological profile of H2S for activating these ion channels. 
Physiologically, inhibition of Kir channels would cause depolarization of cardiac tissue 
(elevating the resting membrane potential to more positive values), lead to several 
electrophysiological phenotypes such as lengthening of the action potential duration (APD), 
whereas, conversely, activation of Kir channels would result in hyperpolarization of cardiac cells 
(depressing the resting membrane potential), and lead to shortening of the APD [81]. 
There is already some evidence of classical Kir (Kir2.x) channel inhibition by another 
established gasotransmitter, carbon monoxide (CO), marked by prolonging the action potential 
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duration (APD) of rat cardiac ventricular myocytes [82]. It was also shown in normal rats, not 
subjected to pathological in-vivo models, H2S administered through NaHS and Na2S led directly 
to decreases in heart rate (HR), cardiac output (CO) despite systemic decreases in peripheral 
resistance [83], which show the direct effects of H2S on the heart itself apart from compensatory 
cardiovascular mechanisms (in which HR and CO would increase in response to decreased 
peripheral resistance). Consistent with the in-vivo results in normal rats, cardiomyocytes of 
ventricular, atrial, and nodal subtypes differentiated from H9 embryonic stem cells (hESCs) and 
human induced pluripotent cells (hiPSCs) also showed slowing of cardiomyocyte contraction 
rates when exposed to a range of exogenous H2S delivered with NaHS [84]. However, the 
apparent beneficial effects of H2S on I/R reperfusion injury models are not always consistent, 
especially when it comes to higher doses of NaHS. For example, in one study, a dose of 
exogenously applied NaHS was shown to be cardioprotective, whereas applying a higher dose 
did not confer any beneficial effects to the irreversible injury [77]. Another experiment showed 
that extended NaHS perfusion also led to desensitization of H2S effects [83] without offering an 
explanation. In addition, H2S has been shown to have a starkly damaging effect when it comes to 
ischemic insults to the brain [85], a distinct tissue type with differential expression of ion 
channels.  
In summary, the contribution of Kir channels, other than probing the role of Kir6.2 
through the co-application of glibenclamide, has not been studied. Experimenters attempted to 
assess Kir contribution using tetraethylammonium (TEA), a non-specific K+ channel blocker, 
and used channel blocker concentrations insufficient to block members of the Kir family of 
channels [83] . The mechanistic details underlying the conflicting effects by H2S need to be 
reconciled in order for hydrogen sulfide to be reliably used as a therapeutic agent to treat cardiac 
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pathologies such as I/R injury. Moreover, we do not understand why H2S hyperpolarizes 
cardiomyocytes [75, 84] whereas it depolarizes cerebral components [86-89] within a certain 
range of concentrations. For example, a diverse subtype of neurons been shown to depolarize 
upon exposure to H2S: subfornical organ (SFO) neurons [88], trigeminal ganglion (TG) neurons 
[86], hypothalamic paraventricular neurons [89], as well as intact tissue such as in entorhinal 
cortex slices [87] and nucleus of the solitary tract [90]. In addition, we lack a clear understanding 
of exactly how H2S is able to offer protective effects in cardiac ischemia whereas it is punishing 
to neuronal tissue undergoing cerebral ischemia, and the role of changed excitability of these 
tissues in their respective pathophysiology needs to be addressed. In particular, the effect of H2S 
on Kir channels needs to be explored given that resting membrane potential changes and thus 
cell excitability depends largely on Kir channels, and some changes in their response to H2S can 
be attributed directly to H2S-Kir channel effects. Because H2S appears to depress the excitability 
of the heart, whereas it increases the excitability of other tissues like the brain, worsening 
seizure-like symptoms, the thorough examination of ion channel targets other than Kir6.2 
channels is critical as well as pinning down the mechanisms underlying their modulation. 
One theme emerging from these studies is that H2S increases the excitability of neuronal 
compartments [86-90], whereas it depresses excitability of cardiac tissues [75, 84], correlating to 
neurotoxic [85, 89] and cardioprotective [16, 76-79] effects, respectively. Therefore, exactly how 
H2S is affecting ion channels that rapidly control membrane excitability, has become a central 
question. In the cardiovascular system for example, H2S stimulates the activity of the ATP-
sensitive Kir6 (KATP) channel through the direct sulfhydration of an N-terminal cysteine (C43) 
residue, hyperpolarizing and dilating blood vessels [75].  
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The KATP channel belongs to the Kir family of K+ channels that establish and regulate the 
resting membrane potential of cardiomyocytes, smooth muscle cells, pancreatic cells, neurons 
and various other excitable cells [81]. A wealth of electrophysiological, structural, and 
biochemical studies has revealed that PIP2 interacts with Kir channels as a key direct activator 
[91]. The cysteine residue (C43) implicated in the effect of H2S on KATP, happens to be 
conserved throughout the Kir subfamily and is positioned next to a positively-charged residue 
critical for coordinating PIP2 binding to Kir3 channels. Therefore, sulfhydration of this nearby 
cysteine may be comparable to other post-translational modifications, such as phosphorylation of 
specific channel residues that directly or allosterically alter channel interactions with PIP2 [53]. 
The effect of H2S on phosphoinositide control of channel activity is thus a critical molecular 
theme to be clarified. More specifically, we explored the putative effect of H2S on cytoplasmic 
cysteine residues of Kir channels (both conserved and distinct).  
Here, we demonstrate that the effect of H2S on Kir channels (Kir2 and Kir3), 
heterologously expressed in Xenopus laevis oocytes, is inhibitory, as opposed to the stimulatory 
effect on KATP channels. We used two approaches to study the effects of H2S on Kir channels by 
exogenous application of NaHS to Kir2 and Kir3 channels or by overexpressing CSE, the 
principal enzyme producing H2S in peripheral tissues. We show that H2S-mediated inhibition of 
Kir channels is dependent on the strength of channel-PIP2 interactions by employing the voltage-
clamp technique on whole oocytes as well as the patch clamp technique in excised membrane 
patches from oocytes. Moreover, we show direct Kir3.2 channel protein sulfhydration using the 
TSA technique and determine by mutagenesis which cysteine residues are involved in the 
inhibitory effect of H2S on this channel. Lastly, using molecular dynamics simulation 
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experiments we provide mechanistic insight as to how sulfhydration of these specific cysteine 
residues leads to changes in channel-PIP2 interactions and channel gating. 
Chapter 2. Materials and Methods 
2.1. Materials and Reagents 
Dioctanoyl (diC8) forms of PI(4,5)P2, were purchased from Echelon (Salt Lake, UT). 
They were dissolved in water to make 6.0 mM stock solutions, which were divided into aliquots 
and stored at -80°C. Further dilutions were made in bath solutions on the day of the experiment. 
LC arachidonyl-stearyl (AASt) PI(4,5)P2 was purchased from Avanti (Alabaster, AL). Aqueous 
stock and working solutions were prepared and sonicated as described [66, 92]. Sodium 
hydrosulfide (NaHS) was purchased from Strem(Newburyport, MA) and dissolved in water to 
make 100 mM stock solutions, which were divided into aliquots and stored at -20°C. Further 
dilutions were made in incubation solution on the day of the experiment. DL-Propargylglycine 
(PAG) was purchased from Sigma-Aldrich, was stored at 100 mM stocks, and used at 5 mM 
working concentrations. Wortmannin was purchased from Tocris (Bristol UK), and dissolved in 
DMSO from Sigma-Aldrich (St Louis, MO) to a stock concentration of 20 mM, and stored at -
80°C and was diluted to a 5 µM working concentration in experiments.  
2.2 Molecular Biology  
A Cys-less mutant of Kir3.2C [93] was provided by the Slesinger lab (Icahn School of 
Medicine at Mount Sinai, NY). Because Kir3.2C (425aa) is a longer splice variant with an 
additional 11aa at the C-terminus, we generated a Cys-less Kir3.2 (414aa) isoform by PCR. The 
Kir3.2(E152D) (referred to as Kir3.2*) mutation that boosts homomeric currents (Yi et al., 2001) 
was introduced and the resulting Kir3.2* (Cys-less) channel was subcloned in the oocyte and 
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mammalian expression vector pXoom, so that it may be compared to the Kir3.2* 2A subtype. 
Desired point and double point mutations were introduced by the commercial QuikChange 
(Agilent Technologies) method. All mutations were confirmed by DNA sequencing 
(Genewiz). CSE constructs in pcDNA3 were cut with BamHI and HindIII and subcloned into the 
pGEMHE vector, cut at SmaI and HindIII sites. 
Xenopus laevis oocyte expression -- All pGEMHE constructs were linearized using the 
NheI restriction enzyme, whereas pXoom constructs were linearized using the XhoI restriction 
enzyme and in vitro–transcribed using the mMessage mMachine® Kit (Ambion) kit. 
Complementary RNA (cRNA) concentrations were quantified by optical density. Xenopus 
oocytes were surgically extracted, dissociated and defolliculated by collagenase treatment, and 
microinjected with 50 nl of a water solution containing the desired cRNAs. All constructs used in 
this study were injected to achieve between 5-20 ng per oocyte, depending on the channel and 
co-injection of CSE, CiVSP or PIP5-Kinase (PIP5K) cRNA. Oocytes were incubated for 2 to 4 
days at 18°C.  
2.3 Electrophysiology  
Whole oocyte currents were measured by conventional Two-electrode voltage clamp 
(TEVC) with a GeneClamp 500 (Axon Instruments) or TEC-03X (NPI) amplifiers. Currents 
were acquired at 10kHz and filtered at 2 kHz using NPI software. Agarose cushion 
microelectrodes were filled with 1.5% (w/v) agarose in 3 M KCl and were used with resistances 
between 0.1 and 1.0 MΩ. Oocytes were held at 0 mV, and currents were assessed by 800-ms 
ramps from −80 to +80 mV (at ramp speed of 200 mV/s). Currents at −80 mV were recorded. 
Barium-sensitive basal currents were defined as the difference between the steady-state currents 
while perfusing a high-potassium (ND96K or HK) solution or a barium solution. The HK 
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solution contained the following: 96 mM KCl, 1 mM NaCl, 1 mM MgCl2, 5 mM KOH/Hepes 
(pH 7.4). The Barium solution consisted of HK + 3 mM BaCl2. Five to twenty oocytes from the 
same batch were recorded for each group, and the experiments were repeated in at least two 
batches. A specialized voltage protocol was designed to activate Ci-VSP submaximally when 
they were co-injected in several experiments, whereby Ci-VSP was activated at +10 mV and 
current levels were monitored by brief pulses to -80 mV. Recovery was analyzed by holding at -
80 mV following a one minute +80 mV depolarization protocol that fully inhibited channel 
current (Fig 7). Data acquisition and analysis were carried out using pClamp9 (Molecular 
Devices) and OriginPro (Microcal) software.  
2.4 NaHS Treatment in TEVC Experiments  
Channels were expressed in Xenopus laevis oocytes. After ~72 hours of expression, the 
vehicle group of injected oocytes was transferred to a petri dish containing 2 mM NaCl added to 
ND96K (High K) solution, whereas the +NaHS group was transferred to a petri dish containing 2 
mM NaHS added to ND96K, sealed with Para film and left to incubate for 100 minutes prior to 
recording (Fig 6). Barium-sensitive basal currents from both groups 1) Vehicle and 2) + NaHS in 
the presence of High K+ (HK or ND96K) solution were assessed at -80 mV using Two-electrode 
voltage clamp. Barium-sensitive currents were normalized to average basal current of vehicle. 
All experiments were tested in at least 2 batches.   
2.5 Wortmannin Treatment and Recording in TEVC Experiments  
 Channels were expressed in Xenopus laevis oocytes. After ~72 hours of expression, the 
vehicle group of injected oocytes was transferred to a petri dish containing 2 mL of ND96K and 
5 µL Dimethyl sulfoxide (DMSO). The +Wort group of injected oocytes was transferred to a 
petri dish containing 2 mL of ND96K and 5 µL 10 mM stock solution of Wort (in DMSO).  
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Figure 6. NaHS Incubation Methodology. Channels were expressed in Xenopus laevis oocytes. 
After ~72 hours of expression, the Vehicle group of injected oocytes was transferred to a petri 
dish containing 2 mM NaCl (and recorded subsequently), whereas the +NaHS group was 
transferred to a petri dish containing 2 mM NaHS, sealed with Para film and left to incubate for 
100 minutes prior to recording. Barium-sensitive basal currents from both groups 1) Vehicle and 
2) + NaHS in the presence of High K+ (HK or ND96K) solution were assessed at -80 mV using 
Two-electrode voltage clamp. Barium-sensitive currents were normalized to average basal 
current of vehicle (2 oocyte group. 
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Figure 7. A schematic demonstrating inwardly-rectifying whole-cell potassium currents in 
Xenopus laevis oocytes using the ramp protocol. When a voltage ramp protocol from -100 mV 
to +100 mV (ramp speed of 200 mV/s) is applied to the oocyte membrane, it changes the 
electrical driving force across the membrane, rapidly altering the membrane potential linearly. 
The length and direction of the arrows correspond to net K+ ion movement and direction of 
movement across the oocyte membrane. Concentration of K+ ions are assumed to be equal across 
the membrane (roughly 90 mM), contributing to 0 chemical driving force across the membrane. 
Top. Voltage ramp protocol applied to the oocyte. Bottom-left: Schematic shows robust net 
inward current corresponding to hyperpolarizing voltage of the ramp protocol (-100 mV), held 
for 100 ms.  Bottom-middle: Schematic shows no net movement of K+ ions (at 0 mV, absence 
of electrical driving force). Bottom-right: Schematic shows significantly less net outward 
movement of K+ ions regardless of application of symmetric depolarizing current (+100 mV), 
held for 100 ms, across the membrane. 
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Oocytes (5-10) from vehicle and +Wort groups were then assayed as described above in 
“Electrophysiology” (TEVC) methods, 120 minutes following incubation. Oocytes from the 
+Wort dish were then transferred to solution containing same solution as the vehicle group (+ 5 
µL DMSO in ND96K). Subsequently NaHS was added to both groups for 100 minutes at 2 mM 
working concentration (as described) and assayed through TEVC recordings. 
2.6. Inside-out Macropatch Experiments 
The vitelline membrane was manually peeled using forceps to gain access to the oocyte 
plasma membrane. Pipettes were pulled using a Flaming-Brown micropipette puller and then 
fire-polished to give a final resistance of 0.8 to 1.2 MΩs. Currents were acquired at 10 kHz and 
filtered at 2 kHz using pClamp software and the Axopatch 200A amplifier (Axon Instruments). 
Inward currents were monitored using a ramp protocol from -100 mV to +100 mV, with the 
holding potential at 0 mV. Following gigaseal formation, the pipette was pulled away from the 
membrane to achieve an inside-out patch, and perfused directly using a multi-barrel gravity- 
driven perfusion apparatus. Pipette solution contained (in mM): 96 KCl, 10 HEPES, 1.8 CaCl2, 1 
MgCl2, 1 NaCl, pH 7.4. Bath solution (in mM): 76 KCl, 20 NaCl, 5 EGTA, 10 HEPES, pH 7.4.  
2.7. NaHS Treatment in Macropatch Experiments 
NaHS dose-response curve (dic8 PIP2). Once the inside-out patch (technique described 
above) expressing Kir2.3 channels was isolated and once the channel activity ran down, the 
patch was subjected to 25 µM dic8 PIP2 until the current reached a steady state, after which, the 
patch was subjected to NaHS treatment in pipette solution for 200 seconds and reactivated by 
diC8 PIP2. Subsequently, the patch was subjected to various concentrations of NaHS for a 200 
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second duration and currents produced by subsequent 25 µM dic8 PIP2 pulses were recorded and 
compared. NaHS dose-response curve (LC-PIP2). We used the same technique as we did to 
generate the NaHS dose response curve pulsed by 25 µM diC8 PIP2, but now we applied ~10 
µM solubilized long-chain PIP2 until currents reached steady-state and then we subjected them to 
varying concentrations of NaHS following 200 second intervals. Dic8 PIP2 dose-response curve. 
Inside out patches expressing Kir2.3 channels were allowed to run down and pulsed by varying 
diC8 PIP2 concentrations, then the same patch was exposed to 100 µM NaHS for 200 seconds, 
and pulsed by the same range of diC8 PIP2 concentrations. 
2.8. TAG Switch Assay  
Presence of sufhydration was determined with a recently designed modified tag switch 
assay [37] by Tyler Hendon (Virginia Commonwealth University), using reagents developed by 
Sumanta Garai and Ganesh Thakur from Northeastern University. First, Kir3.2* was expressed 
and purified from Pichia pastoris by Dr. Takeharu Kawano as described previously [54]. Then, 
approximately 0.6µg/µl of protein was exposed to 1 mM NaHS for 16 min at room temperature 
to trigger sulfhydration of cysteine residues. Next, 10 mM methysulfonyl benzothiazole (MSBT) 
exposure for 15 min at room temperature was used to form R-S-BT and R-S-S-BT adducts at the 
R-SH and R-S-SH moieties of the cysteines, respectively. Excess MSBT was removed by Micro 
Bio-Spin P-6 Gel Columns. A combination nucleophile and reporter molecule, CN-biotin, was 
employed at 2 mM for 1 hour at room temperature in a reaction that is highly preferential to R-S-
S-BT over all other moieties – resulting in a biotin tag detectible on sulfhydrated cysteines only. 
Excess CN-biotin was removed by Micro Bio-Spin P-6 Gel Columns. Next, streptavidin-agarose 
beads were used for 1 hour at room temperature to precipitate biotinylated proteins, followed by 
detection via Western blot using anti-GIRK antibodies. Preparation of 2-
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(methylsulfonyl)benzo[d]thiazole [MSBT]. Periodic acid (1.3 g, 5.80 mmol) was dissolved in 
CH3CN (15 mL) by vigorous stirring at room temperature for 1 h. Then CrO3 (27.5 mg, 0.27 
mmol, 10 mol %) was added to the solution. The mixture was stirred at room temperature for 5 
min to give a clear orange solution. The H5IO6/CrO3 solution was then added dropwise over a 
period of 45 min to a solution of 2-(methylthio)benzo[d]thiazole (0.5 gm, 2.76 mmol) in ethyl 
acetate (30 mL) at 0 °C. After the addition was completed, the reaction mixture was stirred at 
room temperature for 12 h. The reaction was quenched by addition of saturated Na2SO3 solution 
(2 mL) and filtered, and the solids were washed with ethyl acetate (60 mL). The filtrate was 
washed, respectively, with saturated aqueous Na2SO3 solution and brine and then dried over 
anhydrous Na2SO4. The solvent was evaporated under reduced pressure. The crude reaction 
mixture was purified by flash chromatography (hexane/ethyl acetate) to obtain MSBT (0.470 gm, 
82%) as a white solid. 1H NMR (500 MHz, CDCl3): δ 8.22 (d, J=8.3 Hz, 1H), 8.03 (d, J=8.0 Hz, 
1H), 7.63-7.59 (m, 2H), 3.42 (s, 3H); MS-ESI (m/z): 214 [M+H] +. Preparation of 2-(5-
((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)ethyl 2-
cyanoacetate (CN-biotin). This compound was synthesized by following a literature reported 
procedure [37] and the spectral data were matched with the reported compound.  
2.9. Molecular Dynamics Experiments  
Dr. Yu Xu (Northeastern University) conducted Molecular Dynamics (MD) experiments 
reported in this thesis. The Kir3.2* control channel or the sulfhydrated Kir3.2* (added –SH to 
C65, C221-negative control, or C321) channel with 4 PIP2 molecules were subjected to MD 
simulations, in which GROMACS v4.5 was used to conduct the simulation, applying the 
GROMOS96 53a6 force field. The topology files and charges for the PIP2 atoms were calculated 
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using the PRODRG web-server, as described in previous work. Meanwhile, the topology file of 
the sulfhydrated-Cys residue was generated based on existing force field parameters. The 
channel-PIP2 structures were immersed in an explicit POPC bilayer using the VMD membrane 
package, and solvated with SPC water molecules with 150 mM KCl. To mimic the activated 
state, we applied a constant depolarizing electric field of -0.128 mV·nm-1. Energy minimization 
was performed, followed by a 300ps position-restrained (1000 kJ/mol/nm2) MD run. 
Subsequently, the four systems were subjected to a 25 ns MD simulation. Analysis: The 
SIMULAID program was used to analyze/cluster structures, and to calculate interaction 
networks, including hydrogen bonds, salt bridges and hydrophobic contacts.  
3.0. Statistics  
Data are reported as mean ± SEM; n denotes the number of oocytes. Unpaired (two 
sample) t-tests were performed in most statistical analysis of TEVC experiments, and normalized 
currents from oocyte group exposed to NaHS were compared to that of the vehicle (untreated) 
group with an overall significance level of P <0.05 using OriginPro 2016 (Microcal). Currents 
were normalized to the average current of vehicle (untreated) group. To determine whether there 
are significant changes upon exposing oocyte groups to NaHS at increasing time periods, as well 
as increasing RNA injection amounts of CSE, one-way repeated-measures ANOVA were 
performed, and pairwise comparisons were made by the Holm-Sidak method with an overall 
significance level of P <0.05 in OriginPro 2016 (Microcal). Inhibition (±SEM) of currents by 
NaHS in inside-out (I/O) macropatches was normalized to current elicited by PIP2 (prior to 
NaHS treatment), and non-linear fitting of current inhibition was done in OriginPro 2016 using 
the Growth/Sigmoidal category, DoseRep function and Levenberg Marquardt iteration function 
to the following equation:  
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in which, y is the normalized current, x is the concentration of NaHS or diC8 applied to patch, 
A1 is minimum value, A2 is the maximum value, and p is the parameter for the variable hill 
slope.  
Chapter 3. Hydrogen Sulfide Regulation of Kir Channel Activity is PIP2-dependent 
and Mediated by Specific Cysteine Residues 
 
3.1. Dual Role of NaHS on Kir Channels and Sulfhydration of Kir3.2 Channels  
  In contrast to previous studies on stimulation of vascular KATP (Kir6.1) channels [75], 
NaHS (2 mM) treatment inhibited Kir3.2* channel activity (* indicates the E152D mutant that 
increases homomeric channel activity) [94]. NaHS administration to Kir3.2* channels expressed 
in Xenopus oocytes inhibited the whole-cell currents in a time dependent manner, affecting 
Kir3.2* channels maximally at ~100 minutes, whereas treatment for 400 minutes did not produce 
an additional effect (Fig. 8A). Therefore, the effect of NaHS was observed and compared when 
oocyte groups were treated for 100 minutes in successive experiments. In order to explore 
whether the NaHS effect was direct on the Kir3.2 protein, Tyler Hendon employed the TAG 
Switch Assay (as described in Materials and Methods) and observed chemical modification of a 
band corresponding to ~48kDa, which is approximately the expected molecular weight of Kir3.2 
(Fig. 8B). Similar to hydrogen sulfide-mediated inhibition of Kir3.2* channels, NaHS treatment 
diminished currents from oocytes expressing cardiac Kir3.4 channels, both homomeric Kir3.4* 
(* denotes S143T, a mutant shown to boost Kir3.4 homomeric activity) [95], heteromeric 
Kir3.4/Kir3.1 channels (Fig. 8C), and Kir2.3 channels, another Kir subfamily member (Fig. 8D). 
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Interestingly, Kir2.1 activity was unaffected by NaHS treatment (Fig. 8D). Conversely, NaHS 
treatment augmented the activity of the cardiac Kir6.2 channel, consistent with previous 
experiments on the vascular Kir6.1 channel, when it was either co-expressed with SUR2A 
subunits or expressed alone as the recombinant Kir6.2D36 channel (Fig. 8E) in Xenopus oocytes. 
Kir6.2D36 refers to a C-terminal truncation mutant of Kir6.2 that renders these channels active as 
homomers [96], by removing a 3-aa motif [97] that serves as an endoplasmic reticulum (ER) 
retention signal.  
3.2. NaHS Inhibition of Kir3.2* Channels is Dependent on Channel-PIP2 Interactions.   
A common feature of Kir channels is that they all require the membrane phospholipid 
phosphatidylinositol (4,5)-bisphosphate (PIP2) to maintain their activity [67]. The strength of 
Kir-PIP2 interactions determines the sensitivity of Kir channels to several regulatory factors such 
as pH, protein kinase C, and G proteins [54, 69]. Kir2.1 channels, with the highest apparent 
affinity to PIP2 among the channels tested, were unaffected by NaHS treatment, suggesting that 
the extent of NaHS effect may depend on the strength of channel-PIP2 interactions. To test this 
hypothesis, we first altered cytoplasmic PIP2 levels and monitored NaHS-mediated inhibition of 
Kir3.2* channels. First, NaHS-mediated inhibition of Kir3.2* channels diminished when the 
intracellular pool of PIP2 was increased through the co-injection of PIP5 Kinase, a kinase that 
phosphorylates PIP4, into PI (4,5)P2 (Fig. 9A). Conversely, depleting intracellular levels of PIP2 
through co-administration of Wortmannin (Wort), a known blocker of PI4-kinases at µM 
concentrations, permitted greater inhibition of Kir3.2* currents by NaHS (Fig. 9A). Furthermore, 
the NaHS-mediated inhibition was enhanced by Ci-VSP (voltage activated PIP5 phosphatase)  
dependent inhibition of Kir3.2* channels (Fig. 9B), another approach used to deplete the 
intracellular pool of PIP2. Consistent with these results, bolstering Kir3.2*-PIP2 interactions 
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alternatively by co-expressing the G-protein subunit, Gbg, also attenuated NaHS inhibition of 
Kir3.2* current (Fig. 9C). Then we tested what would happen to the extent of NaHS-mediated 
inhibition when Kir3.2 channels themselves were altered intrinsically using known point 
mutations that increase channel-PIP2 interactions. For example, the E152D point mutation in 
Kir3.2* was shown previously to strengthen channel-PIP2 interactions [54], and thus it was not 
surprising to see that NaHS had a greater inhibitory effect on wild-type Kir3.2 homomeric 
channels with a weaker apparent PIP2 affinity than Kir3.2* channels. Moreover, the inhibitory 
effect of NaHS was virtually abolished when the point mutation (I234L) in the background of 
Kir3.2* channels that further strengthens the apparent channel-PIP2 affinity (Fig. 9D).  
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Figure 8. Exogenous H2S Inhibits Kir3.x and Kir 2.x Channels and Activates Kir6.2 
Channels. NaHS-treated currents are normalized to vehicle (untreated) group. A. H2S inhibits 
Kir3.2* (E152D) homomeric channel activity. Incubation of Kir3.2* channels with 2mM NaHS 
elicits time-dependent inhibition. Treatment with NaHS at increasing intervals leads to following 
normalized current values: 1.01 +/- 0.14 (15 min), 0.72 +/- 0.05 (60 min), 0.54 +/- 0.04 (100 
min), and 0.55 +/-0.05 (400 min). Post-incubation, Kir3.2* activity is maximally inhibited by 
~45% at 100 minutes (and not further inhibited at 400 minutes).  B. Tag Switch Assay detects 
sulfhydration of purified Kir3.2 channels treated with NaHS. Left Panel: The exogenous 
application of NaHS (1mM) to GADPH from HEK cell lysates yields a band at ~37 k. Right 
Panel: Exogenous application of NaHS (1mM) to purified Kir3.2 protein leads to detection of 
direct sulfhydration of channel (~47 kDa band). C. H2S inhibits cardiac Kir3.4 (S143T) 
homomeric channel and Kir3.4/Kir3.1heteromeric channel activity. Treatment with NaHS led 
~55% inhibition of Kir3.4* channels (0.45 +/-0.02)  and ~61% inhibition of Kir3.4/Kir3.1 
channels (0.39 +/- 0.02). D. H2S inhibits Kir2.3 channel activity but has no effect on Kir2.1 
channel activity. Treatment with NaHS significantly inhibited Kir2.3 channels (0.74 +/-0.06) but 
did not significantly alter Kir2.1 channel activity (1.04 +/- 0.11). E. Currents from both groups of 
oocytes expressing Kir6.2/SUR2A or Kir6.2Delta36, in which the terminal 36 C-terminal amino 
acids are removed from Kir6.2 to permit cell surface expression in the absence of Sulfonylurea 
receptor (SUR2A) subunits, increased approximately 8-fold (normalized current values of 8.49 
+/- 2.46 and 8.01 +/- 0.73 respectively) upon incubation with 2 mM NaHS, consistent with 
hyperpolarizing findings in Mustafa et. al. (2011), in which Kir6.1 was expressed in HEK293 
cells. * indicates comparison to the untreated group. Single, double, and triple symbols indicate p 
< 0.05,  p < 0.01, and p < 0.001, respectively. 
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3.3. Micromolar Concentrations of NaHS Inhibit Kir2.3 Channels in Macropatch 
Recordings 
 NaHS incubation of whole oocytes expressing Kir channels led to significant inhibition 
of various Kir2.x and Kir3.x channel activities, whereas it stimulated Kir6.2 activity. We 
proceeded to apply NaHS to the cytoplasmic side of excised inside-out patches expressing Kir 
channels to examine directly H2S effects, isolating the channel and other membrane-delimited 
elements from the rest of the cellular cytoplasm. We used Kir2.3, whose relative 
phosphoinositide-interaction profile has been characterized as moderate in previous experiments, 
thus yielding reasonable currents in excised patches. Kir2.3 was inhibited by NaHS in TEVC 
recordings (Fig. 8D). First, we tested the effect of applying NaHS at the micromolar range of 
concentrations and chose to use a single (sub-maximal) concentration of soluble PIP2, diC8 (25 
µM), to compare the relative NaHS effects. Not surprisingly, Kir2.3 channel activity was 
inhibited (Fig. 10A) by NaHS in a dose-dependent manner (IC50 ~ 83 µM), and channel activity  
was maximally inhibited by ~64%, similar to the inhibition measured in whole oocytes incubated 
with NaHS (Fig. 8D). Interestingly, NaHS also elicited dose-dependent inhibition of Kir2.3 when 
the channels were maximally activated with long chain PIP2, (Fig. 10B), but showed a lesser 
extent of inhibition (~37% maximal inhibition) than when Kir2.3 channels were activated by 25 
µM diC8 PIP2 (Fig. 10A), consistent with the decrease of NaHS effects when channel-PIP2 
interactions are strengthened, as seen in the whole oocyte experiments (Fig. 9). Conversely, we 
performed dose-response measurements of PIP2 before and after inhibition by NaHS (100 µM, 
close to IC50 in Fig. 10A) to examine how NaHS treatment might affect channel-PIP2 
interactions. We determined that NaHS treatment to the patch (Fig. 10C and D) right shifted the 
PIP2  dose-response curve, decreasing the apparent affinity of PIP2 demonstrated by the increase 
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of EC50 from 6.2 µM to 9.6 µM. Interestingly, direct NaHS treatment dramatically reduced the 
potency of PIP2, indicated by ~29% reduction in maximal activity following NaHS treatment.  
 
3.4. NaHS Inhibition of Kir3.2* Channels is Mediated by Sulfhydration of Specific 
Cytoplasmic Cysteine Residues  
Hydrogen Sulfide (H2S) is a gasotransmitter that has been shown to signal via 
sulfhydration, a post-translational modification of reactive cysteine residues and conversion of 
the Cys –SH group to an –SSH group. It was previously shown that NaHS is able to sulfhydrate 
a specific cysteine residue, of vascular KATP channels (Kir6.1), leading to eventual 
hyperpolarization and vasodilation of superior mesenteric arteries, and its substitution with serine 
(C43S) abolished the NaHS effects [75]. This specific cysteine residue is conserved throughout 
Kir subfamily members, and positioned adjacent to a positively charged cytoplasmic residue  
shown in the Kir3.2 crystal structure to interact electrostatically with one of the negatively 
charged phosphate groups of PIP2, critical for channel gating [98]. 
In the cytoplasmic region of the Kir3.2 channel, there are three putative cysteine residues 
C190, C221, and C321 that may be sulfhydrated in addition to C65, the conserved cysteine 
residue corresponding to C43 in Kir6.1 channels (Fig. 11A, top panel). In addition to the four 
cytoplasmic cysteine residues, Kir3.2 channels also have two extracellular cysteine residues, 
C134 and C166, located in the extracellular loop region (ECL) and involved in intersubunit 
disulfide interactions. 
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Figure 9. Hydrogen Sulfide Inhibition of Kir3.2 Channels is Altered by Strengthening or 
Weakening Channel-PIP2 Interactions.  A. Increasing PIP2 concentration in the oocyte (and 
thereby increasing channel-PIP2 interactions) through the co-expression of PIP5 Kinase (PIP5K) 
virtually abrogates H2S inhibition of Kir3.2* channels, whereas reduction of PIP2 levels via 
oocyte incubation in 25 µM Wortmannin (Wort, known blocker of PI4-kinases at µM 
concentrations and PI3-kinases at nM concentrations) for 100 minutes in untreated oocytes or co-
incubation (with NaHS), enhanced H2S inhibition from ~40% to ~80% inhibition. B. Decreasing 
PIP2 though activation of co-expressed Ci-VSP, a voltage activated PIP5 phosphatase, also 
reduces intracellular PIP2 and H2S is able to enhance channel inhibition (~70% inhibition 
compared to ~60% inhibition for untreated oocytes). C. Co-expression with Gbg another 
allosteric enhancer of Kir3.2-PIP2 interactions, also reduced the NaHS inhibitory effect on 
Kir3.2* channels (from NaHS treated value of 0.66 +/- 0.05 to 1.08 +/- 0.01). D. H2S effect on 
Kir3.2 weakens when channel-PIP2 interactions are strengthened through point mutations. 
Whereas Kir3.2 (WT) channel is greatly inhibited by NaHS treatment (0.36 +/- 0.06), pore point 
mutation (E152D) in the background of Kir3.2 strengthens channel-PIP2 interaction and 
diminishes Kir3.2 inhibition by H2S (0.62 +/-0.11). Additional point mutation (I234L), in the 
background of the Kir3.2* (E152D) mutation, further strengthens channel-PIP2, completely 
abrogating the H2S inhibition (1.04 +/- 0.11). *indicates comparison to untreated group. Double 
and triple symbols p< 0.01, and p < 0.001 respectively. 
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A functional Kir3.2* ‘Cys-less’ mutant lacking all four cytoplasmic cysteine residues 
(scheme in Fig. 11A, bottom panel) characterized in previous experiments [93] was refractory to 
NaHS inhibition (0% inhibition), and NaHS effect (~37% inhibition) was partially restored by 
reintroducing individual cysteines to the Kir3.2* Cys-less mutants at positions 65 (~18% 
inhibition) or 321(~25% inhibition), and the NaHS effect on Kir3.2* was fully restored through 
reintroduction of both specific cysteines, 65 and 321 (Fig. 11B). Kir3.2* Cys-less mutant 
channels also showed no significant differences in apparent PIP2 affinity compared to Kir3.2* 
channels when tested by the voltage-gated lipid phosphatase Ci-VSP (Fig. 12). More 
specifically, Kir3.2* showed no difference in rate of inhibition compared to Kir3.2* Cys-less 
(2.3s tauInhibition for Kir3.2* and Kir3.2* Cys-less) and no change in recovery rates while 
possessing faster inhibition (compared to tauInhibition of 11.5s) and faster recovery kinetics than 
Kir3.2*(I234L), a channel shown previously to have increased channel-PIP2 interactions (Fig 
12).  
3.5. Cystathionine γ-lyase (CSE) Co-expression Mimics Exogenous NaHS Effects on 
Kir3.2* Channels  
Cystathionine γ-lyase (CSE), is an enzyme central to the production of H2S in cardiac 
tissue and specific regions of the brain (hippocampus and striatal neurons) in physiological and 
pathophysiological conditions [7, 14] and therefore, most likely to be co-expressed in neurons 
with Kir3.2 channels and Kir2.x channels (as well as Kir3.4 channels in cardiac cells). Among 
the three enzymes that produce H2S, CSE seems to be the most inducible and is modulated in 
diverse conditions such as inflammation mediated by tumor necrosis factor (TNF) and 
lipopolysaccharides (LPS), metabolites such as glucocorticoids and glucose, as well as dietary 
restriction and endoplasmic reticulum (ER) stress thereby making it an attractive therapeutic  
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Figure 10. H2S Inhibition of Kir2.3 Channels is Mediated by Micromolar Concentrations of 
NaHS in Macropatches.  A. H2S inhibits Kir2.3 channel activity in macropatches activated 
submaximally by soluble PIP2 (25 µM diC8). Direct administration of varying concentrations of 
NaHS to the cytoplasmic surface of inside-out patches expressing Kir2.3 channels leads to 
concentration-dependent inhibition of Kir2.3 channel activity (IC50 = 82.95 +/-15.47 µM and A1 
value = 0.36 +/- 0.02) when they are pulsed (activated) by 25 µM soluble dioctanoyl PIP2 (diC8). 
B. H2S also inhibits Kir2.3 channel activity in macropatches maximally activated by LC-PIP2 
(full-length PIP2), but to a lesser extent than 25 µM diC8 pulses (Fig. 3A). Direct administration 
of varying NaHS concentrations to the cytoplasmic surface of inside-out patches expressing 
Kir2.3 channels led to concentration-dependent inhibition of Kir2.3 channel activity (IC50 = 
73.21 +/-12.50 µM and A1 value = 0.71 +/- 0.03) when they are activated by full length PIP2. C. 
H2S (100 µM NaHS) reduces the efficacy (increased EC50  values from 6.20 +/-0.50 µM  to 9.60 
+/-1.17 µM) and potency (A2 value decreases from 1.04 +/- 0.04 to 0.74 +/-0.03) of Kir2.3 
channel activation by soluble PIP2 (diC8). D. Representative trace (summarized in Fig. 3C) of 
Kir2.3 expressing inside-out patches subject to various diC8 PIP2 concentrations (0 µM, 10 µM, 
25 µM, 50 µM, 100, µM, 200 µM, and 400 µM) prior to and after exposure to NaHS (100 µM) 
for 200 seconds. 
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target [7, 14]. Co-expression of CSE with Kir3.2* in Xenopus oocytes recapitulated the 
inhibition of Kir3.2* produced by exogenously applied H2S (NaHS), in which increasing the 
cRNA amount co-injected (ranging from 0.5 – 8.0 ng) resulted in a dose-dependent inhibition of 
Kir3.2* currents (Fig. 13A). The Cys-less Kir3.2* channel, refractory to exogenous NaHS 
treatment, was also unaffected by CSE co-expression (Fig. 13B). Acute treatment with 5mM 
propargylglycine (PAG) for 100 minutes, an inhibitor of CSE activity, reversed CSE inhibition 
of Kir3.2*, whereas it did not affect significantly Kir3.2* channels expressed alone (Fig. 13C). 
3.6. Molecular Dynamics Experiments Show Sulfhydration of Specific Cysteine Residues 
Alters Channel Gating and Interactions with PIP2  
In order to gain a better mechanistic understanding about how sulfhydration of a specific 
cysteine residue (the functional effects demonstrated experimentally in Fig. 11B) may affect 
channel-PIP2 interactions as well as channel gating, Dr. Yu Xu performed molecular dynamics 
(MD) simulations with Kir3.2 co-crystallized with PIP2 (PDB code 3SYQ) to model the 
sulfhydration-induced Kir channel inhibition [98, 99]. More specifically, we induced 
sulfhydration of three cysteine residues, C65, C321 (positive effects in Fig. 11B) or C221 (no 
effect in Fig. 11B) and performed a 25ns MD simulation run to observe whether dynamic 
changes occurred to a) the G-loop gate, integral for Kir3.2 channel gating and b) the channel-
PIP2 interactions. First, we surveyed the minimal distances between one of the two phosphates 
on the PIP2 inositol ring and the Lysine residue, K64, previously characterized as critical for 
Kir3.2-PIP2 channel interactions [98] and observed an increase in the distances when C65 (Red) 
or C321 (Gold) residues were sulfhydrated but not when C221 (Green) was sulfhydrated (Fig. 
14A). Dashed lines in the model snapshots taken from the molecular dynamics experiment detail 
how K64 residue moved away from the phosphate on the PIP2 head group when C65 or C321 
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was sulfhydrated (Fig. 14B). Consistent with these observations, scoring the average channel-
PIP2 channel interactions (the limit was specified as being within 0.7 nm), revealed that 
sulfhydration of C65 or C321 (and not C221) residues decreased interactions between the PIP2 
and the channel (Table 1). Dr. Yu Xu then sought to determine whether sulfhydration affects 
channel gating and monitored the minimal distance of the G-loop gate between the alpha carbons 
of T317 on opposite Kir3.2 subunits. We observed a substantial decrease when the C65 or C321 
(but not the C221) residue was sulfhydrated, suggestive of constriction of the G-loop gate 
closure, whereas a minimal change was observed when C221 was sulfhydrated (Fig. 14C). The 
change in G-loop gate conformation is highlighted by model snapshots (Fig. 14D) of the T317 
alpha carbon moving from no sulfhydration (Grey) to C65 (Red), C221 (Green), or C321 
(Yellow). In stark contrast, we observed an increase in channel-PIP2 interactions when a 
homology model of Kir6.2, based on the Kir3.2 structure (PDB code 3SY), was subjected to 
sulfhydration at C42 (homologous to C65 in Kir3.2) (bottom panel, Table 1).  The sulfhydration 
of the C42 also led to increases in distance between the analogous alpha carbons (T294) in an 
MD simulation, suggesting that the G-loop gate opened (Fig. 15), highlighted by the shift of 
T294 alpha carbons (red) away from the non-sulfhydrated Kir6.2 (grey) (Fig. 15, Right Panel).  
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Figure 11.  Specific Cysteine Residues are Sulfhydrated in Hydrogen Sulfide Regulation of 
Kir3.2 Channels. A. Top Panel: Model of sulfhydrated cysteine residues is based on Kir3.2 
structure (PDB code 3SYQ). Sulfhydrated groups (sulfhydrated cysteine -SH groups) modelled 
and mapped on to structure of Kir3.2. Four cytoplasmic cysteines are highlighted: C65, C190, 
C221, and C321.Two extracellular cysteine residues, C134 and C166, located in the extracellular 
loop region (ECL) and involved in intersubunit disulfide interactions, were not 
mutated.  Highlights show location of C65, and how sulfhydration (space-filling models) may 
directly interfere with channel-PIP2 interactions, whereas, C321, when sulfhydrated may give 
rise to allosteric modifications at the G-loop directly as well as indirectly affect channel-PIP2 
interactions.  Bottom Panel: Scheme of functional Kir3.2* Cys-less mutant previously 
characterized as having intact basal current, response to agonist-induced current [93]. The four 
cytoplasmic cysteine residues mapped in (A) are mutated to the following residues (from N-
terminus to C-terminus): C65V, C190T, C221S, and C321V.  B. Kir3.2* Cys-less mutant 
activity is entirely insensitive to H2S. NaHS incubation is unable to inhibit Kir3.2*Cys-less 
mutant (0.985 +/- 0.06). Preliminary data reveal that the strength of Cys-less mutant-PIP2 
interaction is not significantly different from that of Kir3.2*. Re-introducing single cysteine 
residues to positions 65 and 321 partially restores H2S inhibition by ~18% (0.82 +/- 0.04) and 
~33% (0.67 +/- 0.06) respectively, roughly additive to ~52% inhibition of Kir3.2* (0.58 +/- 0.03)  
with all four cytoplasmic cysteine residues. Re-introducing single cysteine residues to positions 
190  and 221 do not significantly restore H2S inhibition (0.91 +/- 0.06 and 0.94 +/-0.15 
respectively). * indicates comparison to untreated group. Triple symbols (***) indicate p < 
0.001.  
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Figure 12. Strength of Channel-PIP2 interactions are similar between Kir3.2* and Kir3.2* 
(Cys-less) Channels. A. Voltage protocols (in mV) used for inhibition (top) and recovery 
(bottom). B. Kir3.2* and Kir3.2* (Cysless) displayed faster current inhibition compared to 
Kir3.2*(I234L). C. Tau values for inhibition for Kir3.2* of 2.56 +/- 0.06 s and Kir3.2*(Cysless) 
of 2.78 +/- 0.04 s were not significantly different. However, both tau values were significantly 
less than that of Kir3.2*(I234L) of 10.1 +/- 0.72s. *** p<0.001 compared to control. D. Kir3.2* 
and Kir3.2* (Cysless) showed slower recovery time than Kir3.2* (I234L) at -80 mV. 	
 
 
 
 
 
 
 
 
Ha et. al. 2017, In submission to Journal of Biological Chemistry 
		 54 
 
Figure 13. Expression of CSE, Enzymatic Producer of H2S, Mimics NaHS Effects 
A. Co-injection of cystathionine γ-lyase (CSE), integral to the production of H2S in specific 
mammalian tissues at physiological concentrations, recapitulates inhibition of Kir3.2* produced 
by exogenously applied H2S (NaHS). Increasing CSE mRNA co-injected into oocyte (with 
Kir3.2* channel), increases significantly Kir3.2* inhibition in a dose-dependent manner, 0.74 +/- 
0.05, 0.66 +/- 0.06, and 0.56 +/- 0.06 for 0.5ng, 4.0 ng, and 8.0 ng injections respectively.  B. 
Kir3.2* Cys-less activity is refractory to CSE co-injection. Mutating all four cytoplasmic 
residues mentioned in Fig. 11A removes the inhibitory effect of co-expressing CSE (1.00 +/- 
0.06) compared with  that of Kir3.2* WT (0.62 +/- 0.05), strongly suggesting that the reduced 
Kir3.2* activity is not due to taxing the mRNA machinery in oocytes with a non-specific RNA 
load. In addition, CSE inhibition requires cytoplasmic cysteine residues as was the case with 
exogenously applied NaHS. C. Treatment with propargylglycine (PAG), an inhibitor of CSE 
activity, reversed CSE inhibition of Kir3.2* (from 0.56 +/- 0.11 to 0.90 +/- 0.09). * indicates 
comparison to only channel injected. † indicates comparison to co-injection with 0.5 ng CSE. 
Double, and triple symbols indicate p< 0.01, and p < 0.001 respectively.  
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Figure 14. Molecular Dynamics Experiment provides Mechanistic Insight into How 
Sulfhydration of Specific Residues on Kir3.2 Channels affect channel-PIP2 Interaction 
and Channel Gating. MD Simulation (25 ns) reveals how sulfhydration of C65, disrupts direct 
channel-PIP2 interactions, between adjacent K64 and PIP2, consequently leading to closure of the 
G-loop Gate (decrease in distance between alpha carbons of T317 on opposite subunits). A. Left 
Panel: MD Simulation subjecting models of Kir3.2* (no cysteine modification) and three of the 
cysteine-modified, sulfhydrated Kir3.2* channels (C65, C221, and C321) with 4 PIP2 molecules 
for 25 ns revealed structure-dynamics-function relationship of a PIP2 interacting residue, K64 
(highlighted in Fig. 11A in the N-terminus region). In this simulation, the distance between K64 
and PIP2 increases in the Kir3.2* model with sulfhydrated C65 or C321 (but not the Kir3.2* 
models with sulfhydrated C221 or C190 – not shown), suggestive of how H2S may directly 
interrupt the K64-PIP2 interactions. Right Panels: Model snapshots taken from molecular 
dynamics experiment details how K64 residue (left, no modification) moves away from 
phosphate on PIP2 head (distance between residue and PIP2 (dotted black lines) increases from 
8A (no sulfhydration) to 14.9 Å and 10.4 Å for models with C65-SH and C321-SH respectively, 
whereas no substantial change is detected in the model with C221-SH. B. Left Panel: The G-loop 
Gate in Kir3.2* closes only when C65 or C321 is sulfhydrated, suggested by the decrease of 
distance between T317 alpha carbons of opposite subunit G-loops (indicative of closing of G-
loop gate when C65 or C321 is sulfhydrated). Right Panels: Alpha carbons of T317 residue move 
closer (gate closing) from no modification (grey) to when C65 (red) or C321(yellow) is 
sulfhydrated in MD simulations whereas relatively no change is evident when C221 (green) is 
sulfhydrated.  
 
 
 
Figure generated by Dr. Yu Xu.  
Ha et. al. 2017, In submission to Journal of Biological Chemistry 
		 56 
Figure 15. Molecular Dynamics Experiment Provides Mechanistic Insight as to how 
Sulfhydration of C42 is Permissive Towards Kir6.2 Channel Opening. Left Panel: The G-
loop gate in Kir6.2 channel opened when C42 was sulfhydrated, suggested by the increase in the 
distance between T294 alpha carbons of the G loops of opposite subunits. Right panel: Top view 
(right) showed how the T294 residue moves away (gate opening) from no modification (grey) to 
when C42 was sulfhydrated (red). 
 
 
 
 
 
 
 
 
 
Figure generated by Dr. Yu Xu. 
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Table 1. Molecular Dynamics Experiment Reveal Direct changes in Channel-PIP2 
Interactions (Total contact between PIP2 head group and Channels, A.U.) 
Top: Kir3.2. Contact frequencies of PIP2 head groups with channel diminished in MD 
simulations with sulfhydrated C65 or C321 and not C221, consistent with experimental results.  
Bottom: Kir6.2. Contact frequencies of PIP2 head groups with channel increased with 
sulfhydrated C42, consistent with experimental results. 
 
 
 
 
 
 
 
 
 
Table values produced by Dr. Yu Xu.  
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Chapter 4. Carbon Monoxide Inhibition of Kir2 and Kir3 Channels is also PIP2-
dependent and mediated by a Specific Cysteine Residue 
 
Carbon monoxide (CO) is produced endogenously by the catabolism of heme by heme 
oxygenases (analogous to the enzymatic production of hydrogen sulfide by CBS, CSE, or 
CAT/MST) or exogenously by the partial combustion of hydrocarbon sources.  Its physiological 
actions have also shown to be greatly beneficial to cardiovascular disease, such as the relaxation 
of vascular smooth muscle involving BK channels. Yet like hydrogen sulfide, in high exogenous 
levels CO can act as a toxin and cause arrhythmogenesis and death. While previous studies have 
shown carbon monoxide (CO) inhibits Kir 2.x channels in cardiomyocytes, we sought to see 
whether we could reproduce this result in the heterologous Xenopus system and aim to identify 
CO-sensitive residues as we did for hydrogen sulfide. 
When CORM2 (100 uM), a Rubidium-based CO donor, was applied directly to whole 
oocytes expressing Kir channels, we observed ~40% steady-state inhibition in Kir2.3 channel 
current and no change in current in the Kir2.1 channel (Fig. 16), characteristic of the ability of 
hydrogen sulfide’s ability to inhibit Kir2.3 channel and its inability to inhibit the Kir2.1 channel 
that displays stronger channel- PIP2 interactions. CO-mediated inhibition of about 55% was 
recapitulated in Kir3.1* currents. However, the inhibitory effect of CORM2 on Kir2.3 was 
abolished when the cysteine residue (C28) analogous to Kir3.2* (C53), near the direct channel 
interaction site with PIP2, was mutated to alanine (Fig 17). In addition, CO (100uM CORM2) 
was able to inhibit the Kir2.3 channel when a different cysteine residue (C160) was mutated to 
alanine, indicating that C28 may specifically confer CO-sensitivity to Kir2.3 channels. 
 CORM2 was also able to inhibit Kir2.3 channels expressed in macropatch preparations, 
devoid of cytoplasmic constituents in a dose-dependent manner whether the current was being 
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evoked submaximally by diC8 (Fig. 18A) or maximally by long-chain PIP2. (Fig 18B). 
Analogous to the inhibition by hydrogen sulfide of macropatches expressing Kir2.3, CORM2 
increased the pEC50 of PIP2 from 25 µM to 45 µM and reduced the efficacy by 65%. Combined 
with the TEVC data, we present preliminary evidence which shows that CO acts on specific 
residues in K channels to modulate channel-PIP2 interactions and thus channel activity.  The 
cysteine residues on Kir channels may serve as a hub for competing gasotransmitters, hydrogen 
sulfide, carbon monoxide, as well as nitric oxide (not tested) in physiological or 
pathophysiological conditions.  
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Figure 16. Carbon Monoxide (CO) Inhibition of Kir2.3 Channels is PIP2-dependent. Direct 
application of Kir2.3 channels with 100 uM CORM2 inhibits channel activity. A. CORM2 
inhibits Kir2.3 (IRK3) channel and Kir3.1* channel activities but has no effect on Kir2.1 (IRK1) 
channel activity. * indicates comparison to the untreated group. Triple symbols indicate p < 
0.001. 
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Figure 17. CO Inhibition of Kir2.3 Channels depends on Cysteine 28 (and not Cys 170). 
Kir2.3 (C28A) activity is entirely insensitive to CORM2. CORM2 application is unable to inhibit 
Kir2.3 mutant. Mutation of single cysteine residue at position 170 does nothing to alter Kir2.3 
sensitivity to CO inhibition. * indicates comparison to untreated group. Triple symbols indicate p 
< 0.001.  
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Figure 18. CO Inhibits Kir2.3 Channels in Macropatches in a Dose-Dependent Manner. A. 
Carbon monoxide (100 µM CORM2) reduces the efficacy and potency of Kir2.3 channel 
activation by soluble PIP2 (diC8). B. CO also inhibits Kir2.3 channel activity in macropatches 
maximally activated by LC-PIP2 (full-length PIP2). Direct administration of varying CORM2 
concentrations to the cytoplasmic surface of inside-out patches expressing Kir2.3 channels led to 
concentration-dependent inhibition of Kir2.3 channel activity when they are activated by full 
length PIP2.  
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Chapter 5. Discussion 
The “dual functional effect” exerted by hydrogen sulfide is exemplified by neuronal  
versus cardiovascular cells that are deprived of oxygen. H2S mediates ischemic damage pursuant 
to stroke in neuronal tissue [85], whereas it serves as a powerful cardioprotective agent upon 
comparable conditions. One categorical correlation that emerged in the studies highlighting this 
‘dual physiological effect’ by the gaseous mediator is that while H2S depolarizes cerebral 
components [86-90], it hyperpolarizes cardiomyocytes [75, 84]. In other words, H2S increases 
the excitability of cerebral tissue, worsening seizure-like symptoms and becoming more 
susceptible to ischemic insult [85, 89].  In contrast, it depresses the excitability of the heart, in 
which H2S is cardioprotective in ischemia and reperfusion (I/R) injury models when 
administered either through a pre-I/R [16, 76, 77] or post-I/R [78] treatment. The link between 
the effect of H2S on tissue excitability and the clinical phenotype is especially evident when the 
blocking of a single ion channel, KATP, by glibenclamide, abrogated the cardioprotective effects 
H2S had on the I/R injury models [77, 78]. Thus, subsequent efforts have been made to identify 
key ion channels that contribute to the depolarizing effect of H2S on neuronal cells as KATP 
mediates hyperpolarization in the cardiovascular system and have been inconclusive in 
identifying the specific ion channels affected in specific neuronal tissues [86-90]. Relying on ion 
channel blockers with limited specificity has made it difficult to reliably pin the effect of H2S on 
observed depolarizations in neurons to specific ion channels. For example, a dose of blockers 
applied, like TEA that is a non-specific K+ channel blocker, would barely block most K+ 
channels in native tissues [100]. Notably, several members of the Kir family of K+ channels 
(Kir2.x and Kir3.x) like other K+ channels that are not readily blocked by the concentration of 
agents used in these experiments, are intriguing potential targets of H2S as they are differentially 
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expressed in neuronal and cardiac tissues, where they establish the resting membrane potential 
and modulate their excitability [81]. 
Here we show for the first time that NaHS inhibits Kir2.x and Kir3.x channels expressed 
heterologously in Xenopus oocytes (Fig. 8), while it activates the closely related cardiac and 
pancreatic subunit of the KATP channel subtype, Kir6.2 (confirming previous experiments on the 
effect H2S has on other Kir6.x subtypes). The significant inhibition of Kir2.x and Kir3.x 
channels is surprising given their homology to Kir6.x and is consistent with the depolarizations 
observed in NaHS-treated native cerebral components. Furthermore, we have demonstrated that 
NaHS administration can directly sulfhydrate purified Kir3.2 channels (Fig. 8C) in vitro, via the 
TAG Switch Assay (TSA). As with other known modulators of Kir channel activity, we have 
demonstrated that the effect of H2S on Kir channels proceeds by altering the strength of channel-
PIP2 interactions. Bolstering channel-PIP2 interactions (Fig. 10A, 10C, 10D) protected Kir 
channels from H2S effects, whereas Kir channels became more susceptible to H2S when channel-
PIP2 interactions were weakened (Fig. 10A, 10B). We also show here, that the inhibitory effect 
of H2S on Kir3.2* channel is mediated by two of four cytoplasmic cysteine residues, C65 and 
C321 (but not C190 and C221) in each of four channel subunits that form tetrameric Kir3.2 
channels. The substitution of all four cytoplasmic cysteines abolished the inhibitory effect of 
H2S, without altering the strength of channel-PIP2 interactions (Fig. 12). The reintroduction of 
cysteines into positions 65 or 321 in the background of the Kir3.2* Cys-less mutant partially 
restored H2S-mediated inhibition, and reintroduction of both cysteines fully restored the extent of 
H2S mediated inhibition. Our computational MD simulations experiments that modelled the 
structural changes upon sulfhydration of Kir3.2 channel provided predictions that are in 
		 65 
agreement with the experimental data. Direct sulfhydration of specific cysteines, C65 and C321 
(and not C190) led to increased distances between K64 residue and PIP2 phosphates (Fig. 14A 
and Table 1) as well as changes in the G-loop gate favoring the closed conformation (Fig. 14C-
D) providing mechanistic insight into the inhibitory effect of H2S.   
While previous experiments have applied micromolar (5-200 µM) concentrations of 
NaHS, within the physiological range of reported hydrogen sulfide in mammals [85], we 
administered a 10-fold higher concentration of NaHS (2,000 µM) to elicit a significant response 
in Xenopus oocytes. We attribute this extended treatment (for 100 minutes) and increased NaHS 
concentration requirement to the expansive size of Xenopus oocyte, relative to mammalian cells 
exposed to NaHS, as well as the stockpiling of beta-globin in these cells, that could serve as a 
major buffer for hydrogen sulfide [101]. It is noteworthy that this stringent NaHS administration 
led to channel-specific inhibitory effects, as it was unable to affect Kir2.1 channel activity as 
well as the Kir3.2* (I234L) mutant, two channels displaying higher apparent affinities to PIP2, 
whereas it activated (rather than inhibited) Kir6.2 channels. Still, in order to ensure we are not 
observing toxic effects of NaHS on Kir channels, we demonstrated that the inhibitory effect of 
NaHS on Kir3.2* channels could be mimicked by facilitating endogenous production of 
hydrogen sulfide through the co-expression in Xenopus oocytes of cystathionine g-lyase (CSE), a 
key producer of endogenous H2S in native cardiovascular and specific neuronal tissues. As with 
oocytes administered NaHS, the Kir3.2*(I234L) mutant, with increased apparent channel-PIP2 
affinity, was refractory inhibition when co-expressed with CSE, and co-incubation with PAG, an 
inhibitor of CSE, abolished the inhibition of Kir3.2* channels. Additionally, we employed NaHS  
in the micromolar range of concentrations directly to the cytoplasmic side of Xenopus inside-out 
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patches expressing Kir 2.3 channels in inside-out macropatches, separating the membrane-
delimited elements from the rest of the cellular cytoplasm. As expected, Kir2.3 channel activity 
was greatly inhibited (Fig. 10A) by much lower concentrations of NaHS in a dose-dependent 
manner (IC50 ~83 µM), and channel activity was maximally inhibited by ~64%, similar to the 
inhibition measured in whole oocytes incubated with stringent levels of NaHS (Fig. 8D). 
Interestingly, maximally activating patches with Kir3.2* with long chain PIP2 (2 µM) exhibited 
lesser NaHS-mediated inhibition (~37% maximal inhibition) compared to when Kir2.3 channels 
are activated by a submaximal concentration of PIP2 (25 µM diC8 PIP2, Fig. 10A), consistent 
with the diminished NaHS inhibition when channel-PIP2 interactions were strengthened in the 
whole oocyte experiments (Fig. 9). Also, PIP2 efficacy and potency were weakened by NaHS 
treatment (Fig. 10C) indicated by the ~29% reduction in maximal activity and a rightward shift 
of the diC8 PIP2 dose-response curve respectively following NaHS treatment. These findings are 
consistent with the MD computational simulation results, in which conformational changes are 
induced by sulfhydration of cysteine residues, leading to weakened channel-PIP2 interactions and 
the closing of the G-Loop gate (Fig. 14). Interestingly, our computational predictions are also in 
agreement with the activation of Kir 6.2 by H2S (Fig. 8E), showing sulfhydration of C42 (works 
in a way opposite to modification of cysteines in the Kir3.2 model) in a homology model of 
Kir6.2 (based on the Kir3.2 structure), leads to strengthening of channel-PIP2 interactions and 
opening of the G-Loop gate (Fig. 15).  
The mechanisms underlying differential regulation of Kir6.x channels from that of Kir3.x 
channels need to be further explored. Despite sharing remarkable homology, hydrogen sulfide 
has an activating effect on Kir 6.x channels opposite of its inhibitory effect on Kir 2.x and Kir3.x 
channels, revealed by the results in this thesis. Whether hydrogen sulfide’s activating effects on 
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Kir 6.x is solely mediated through C42 needs to evaluated by similar cysteine-mutation 
experiments done with Kir 3.2 channels. In addition, the direct sulfhydration of Kir 6.x channels 
requires testing by TAG-switch assay and mass spectrometry as there are existing conflicting 
modified Biotin switch assays that potentially complicate whether the Kir6.x channels or 
auxiliary SUR subunits are directly sulfhydrated.  
We demonstrate the effect of H2S on Kir2.x and Kir3.x is inhibitory, in the opposite 
direction of the previously characterized Kir6.x channel activation despite their homology. Their 
inhibition by H2S could be a critical factor in the NaHS-mediated depolarizations observed in 
native tissue compartments like in neurons, as Kir2.x and Kir3.x inhibition would have a 
depolarizing influence on specific tissue types that express these subtypes, making them more 
excitable. Whereas activation of Kir channels (Kir6.), such as in cardiomyocytes or colonic 
smooth muscle cells [102] would have the opposite hyperpolarizing influence on specific cell 
types that express this Kir subtype robustly, making them less excitable. Our findings may 
provide a potential explanation for the depolarization of certain specific cells, while they do not 
rule out a role for other affected ion channels. Future studies evaluating the collective effect of 
H2S on specific native brain tissues will need to at least address the differential expression of Kir 
channels [103]. One explanation as to why H2S raises the excitability of specific tissues may be 
because its depolarizing influence via inhibition of Kir2.x and Kir3.x channels is simply greater 
than its opposing influence on Kir6.x channels (whereas the hyperpolarizing influence of H2S 
dominates in specific tissue cell types, like native cardiomyocytes and smooth muscle cells). 
Here, we also show that the inhibitory effect of H2S is PIP2-dependent, in which increasing the 
strength of channel-PIP2 interactions protects the Kir2.x and Kir3.x channels from H2S inhibition 
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and weakening them makes them more susceptible to H2S inhibition. Our work identifies new 
physiological targets of H2S and offers mechanistic insights into the inhibition of Kir channels by 
H2S.  
Chapter 6. Future Directions 
The major physiological undercurrent of this thesis work that the varied tissue-specific 
changes in membrane potential (depolarization or hyperpolarization) in response to hydrogen 
sulfide may be, to a certain extent, explained by the differential expression of Kir channels in 
various tissues requires further examination. More specifically, specific cells (like neurons) with 
greater hydrogen sulfide effect on Kir2.x/3.x channels relative to that on Kir6.x channels would 
elicit a net depolarized change whereas cells with greater hydrogen sulfide effect on Kir6.x 
channels would yield a net hyperpolarizing effect. Thus, hydrogen sulfide may exert disparate 
depolarizing or hyperpolarizing influence on the tissue cell type depending on its competing 
inhibitory influence between Kir2.x/Kir3.x channels and Kir6.x channels. The results in this 
thesis clearly demonstrate that the sulfhydration of cytoplasmic cysteine residues in the Kir 
channel alters gating and activation by the phospholipid PIP2 in a heterologous Xenopus laevis 
system. Future experiments need to address the actions of hydrogen sulfide on native mammalian 
cells such as neurons that express a differential mixed population of Kir channels (Kir2.x/Kir3.x, 
Kir 6.x channels, as well as other Na+, Ca2+, and Cl- channels) and determine whether the results 
in the heterologous system can explain the net effect on native cells. Previous experiments have 
shown that hydrogen sulfide has a depolarizing effect on neurons [86-89], but they have been 
unable to determine which ion channels are eliciting the hydrogen sulfide-mediated 
depolarization. The common strategy in these endeavors has been to co-apply selective ion 
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channel blockers simultaneously with hydrogen sulfide to see which channel blocker reverses the 
depolarizing effect on neurons. Given the results in this thesis, future experiments ought to use 
more selective blockers of Kir Channels such as Tertiapin Q (specific blocker of Kir1.1, 
Kir3.1/3.4, and Kir3.1/Kir3.2 channels) simultaneously with hydrogen sulfide rather than TEA, 
employed by previous experiments, which at the reported range of concentrations is unable to 
block Kir channel currents. Also, previous experiments assaying the effects of hydrogen sulfide 
on cardiomyocytes often demonstrate the hyperpolarizing effects based on narrow concentration 
of hydrogen sulfide and dismiss any reversal of the hyperpolarizing effect without adequate 
explanation. Future experiments need to apply increasing concentrations of NaHS on native 
cardiac cells to observe whether differential pharmacological effects occur, such as the NaHS 
being able to influence greater population of Kir channels other than Kir6.1.  
While this thesis work provides invaluable mechanistic explanation as to how hydrogen 
sulfide inhibits Kir2.x and Kir3.x channels, single-channel experiments could further elucidate 
whether the hydrogen sulfide 1. removes functional channels from the population, 2. reduces the 
unitary conductance of channels, and/or 3. reduces the mean open probability of the channel. 
Previous single channel recording studies have already shown that NaHS affects Kir6.x channel 
opening, rather than the number of functional Kir6.x channels at the membrane or unitary 
conductance. 
 Some other ambiguities still persist in the mechanism underlying Kir channel inhibition 
by hydrogen sulfide.  For example, it is not exactly clear how strengthening channel-PIP2 
interactions protects Kir channels from inhibition by hydrogen sulfide, and how weakening 
channel-PIP2 interactions intensifies the hydrogen sulfide inhibitory effect. One explanation is 
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that channel-PIP2 interactions simply protect specific cysteine residues from sulfhydration by 
hydrogen sulfide, thereby preventing the hydrogen sulfide effect. Another explanation is that the 
cysteine residues are not protected, and hydrogen sulfide is able to sulfhydrate the specific 
cysteine residues readily and exert an inhibitory effect on the channel in opposition to the net 
stimulatory influence by PIP2.  If hydrogen sulfide were to win out in this “tug of war” model 
and overcome the channel-PIP2 interactions, it would also be able to exert a net inhibitory effect 
whereas no net effect would occur if channel-PIP2 interactions are able to overpower the 
inhibitory influence placed by sulfhydrated cysteine residues. The distinction between these two 
simplified models may be tested by employing the TAG Assay and observing whether channel 
sulfhydration levels are affected by co-administration of PIP2 (although, the TAG Assay method 
in this thesis removes the channel from the lipid bilayer environment).  
Interestingly, NaHS not only weakens channel-PIP2 interactions by increasing the diC8 
EC50 (Fig. 10B) but it also reduces the efficacy of the channel so that additional PIP2 is unable to 
maximally activate the patch containing the channels modified by NaHS. The macropatch set up 
also gives us the opportunity to conduct future experiments that examine whether NaHS has a 
channel state dependent effect, whether the open or closed state of the channel affects the extent 
of NaHS inhibition. It would not be surprising if future experiments revealed that activated 
channels have more resilience to NaHS inhibition, given there would be more PIP2 within the 
vicinity of the channel. The converse would be true given, there is less channel activation when 
there is less PIP2 in the vicinity. 
The TAG assay (Fig. 8B) results in this thesis is encouraging but not sufficient in 
providing evidence that Kir3.2 channel is directly sulfhydrated by exogenous NaHS. Additional 
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TAG assay experiments with controls, such as purified channel protein (not exposed to NaHS) 
and increasing concentrations of NaHS, and NaHS exposure of channel proteins lacking specific 
cysteine residues would reveal whether 1) purified channel is endogenously sulfhydrated (and to 
what extent), 2) increasing NaHS exposure alters the extent of channel sulfhydration, and 3) 
specific cysteine residues are differentially sulfhydrated. For example, if purified Kir3.2 channel 
lacking cysteine residues does not get pulled down by streptavidin would inspire greater 
confidence in the TAG assay. Additionally, the field would benefit greatly if mass spectrometry 
experiments would provide another independent approach to show sulfhydration by hydrogen 
sulfide on the specific cysteine residues as well as other post-translational modifications that are 
not limited to the specific cysteine residues. Post-translational coverage by mass spectrometry 
would also reveal other potential modifications on the cysteine residues (as well as all residues 
on the protein) and merits overcoming the challenge that lies in optimizing mass spectrometry 
conditions to allow for better coverage of modified Kir residues. 
Another technical issue in electrophysiological experiments using NaHS is that hydrogen 
sulfide rapidly evaporates into the open atmosphere, requiring the immediate use of NaHS 
solutions just prior to experiments. Previous experiments have implied that nearly 75% of 
hydrogen sulfide can dissolve out of aqueous solution within 30 minutes, casting some 
uncertainty to how representative the actual hydrogen sulfide concentration values used in the 
TEVC and macropatch experiments. Future experiments could utilize another hydrogen sulfide 
donor that releases hydrogen sulfide less rapidly than NaHS to prevent the rapid loss of hydrogen 
sulfide in open experimental solutions. In addition, future experiments can be performed in more 
closed experimental environments to prevent diffusion of hydrogen sulfide at the reservoir.  
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In addition, we have preliminary evidence (data not shown) that increasing PIP2 levels 
diminishes the activating effect of hydrogen sulfide on Kir6.x channels, which is consistent with 
our results that increasing channel-PIP2 interactions reduces the inhibitory hydrogen sulfide 
effect in Kir2.x and Kir3.x channels. The mechanisms underlying how hydrogen sulfide 
differentially regulates Kir2.x/Kir3.x channels and Kir6.x channels requires further exploration, 
given that the Kir channels, despite belonging to the same family, have diametrically opposite 
responses to hydrogen sulfide. One putative reason for the different responses may be that 
hydrogen sulfide may relieve Kir6.x channels from tonic inhibition by ATP (which does not 
affect other Kir channels). Expressing Kir6.x channels in macropatches and exposing them to 
different rage of NaHS and ATP to the cytoplasmic side of the patch would clearly show whether 
NaHS affects channel inhibition by ATP. Extensive future experiments that swap structural 
motifs (or amino acids) distinct between Kir2.x/3.x and Kir6.x channels may reveal key 
structural determinants that elicit inhibitory or stimulatory response to hydrogen sulfide.  
Lastly, the specific cysteine residues that play a critical role in NaHS regulation may also 
be subjected to differential regulation by other gasotransmitters like carbon monoxide (CO) and 
nitric oxide (NO), that are ubiquitous players under physiological and pathophysiological 
circumstances. Already, experiments on Kir channels with CORM2 have revealed that one of the 
cysteines involved in hydrogen sulfide regulation may also be involved in CO mediated 
inhibition. Future experiments will need to address the reversibility of the hydrogen sulfide 
effect, as well as how carbon monoxide (briefly discussed in this thesis) or nitric oxide (via 
nitrosylation, not explored in this thesis) may compete with or add to hydrogen sulfide inhibition 
on Kir channels and how the extent of their regulation may also be dependent on channel PIP2 
interactions. 
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